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Abstract 
Systems biotechnology is an approach to develop comprehensive and ultimately 
predictive models of how components of a biological system reproduce its observed behavior. 
The major human diseases like as diabetes, obesity, high blood pressure, cardiovascular 
disease and cancer are involved in failure of human metabolic systems. Therefore, 
metabolism is an important biological process, but these are complex and highly 
interconnected each others. Metabolic network maps are represented by a complex chain of 
chemical reactions and are highly associated between genes, proteins and enzymes; 
consequently mathematical and/or computational approaches are necessary for integration of 
them. Heterogeneous biological data, including genome, transcriptome, proteome, and 
metabolome are integrated into a pathway-based metabolic model to predict a flux 
distribution of genetically modified cells under particular conditions. The integration of 
heterogeneous biological data and model building have become essential activities in 
biological research as technological advancements continue to empower the measurement of 
biological data of increasing diversity and scale. But the challenge becomes how to integrate 
this data to maximize the amount of useful biological information that can be extracted.  
Metabolic pathway analysis is theoretically effective in integrating heterogeneous 
biological data into metabolic network and to offer great opportunities for studying functional 
and structural properties of metabolic pathways. Metabolic pathway analysis has focused on 
two approaches, namely, elementary modes (EMs) and extreme pathways (Expas). EM 
analysis is potentially effective in integrating  transcriptome or proteome data into metabolic 
network analyses  and a minimal set of reactions that can maintain the steady state level, 
while Expa analysis is a subset of EM that contains two additional conditions and one of 
them condition to make all Expas systematically independent. The EM coefficients (EMCs) 
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indicate the quantitative contribution of their associated EMs and that can be estimated by 
maximizing as a particular objective function.  
A serious problem of EM/ Expa analysis is that the computational time increases 
exponentially with an increase in network sizes, which makes the computation of the all 
EMs/Expas expensive and impracticable for large- or genome-scale networks. Another major 
problem is that many organisms still does not have provide any specific objective biological 
function for estimating the EMCs to predict the flux distribution relate to the optimum 
physiological states and EMs can be described by different scalar products or many possible 
vectors of each EM, but the predicted flux distributions must be independent of them.  
To address such aforementioned problems, in this thesis we present a fast and 
efficient algorithm, called complementary EM (cEM) analysis, to reduce the number of 
EMs/Expas. To achieve the computational time improvement, we employ the EM 
decomposition method that explores major EMs or linear combinations of them which are 
responsible for the metabolic flux distributions. Flux balance analysis (FBA) is used to 
generate many possible ranges of metabolic flux distributions as the input data, which is  
necessary for the EM decomposition method. The maximum entropy principle (MEP) is used 
as an objective function for estimating the coefficients of cEMs, to renounce the scalar 
product problem of  EMs. MEP is widely used for flux prediction in particular cases where 
no biological objective function is available and most advantages that it does not depend on 
the scalar product of each EM.  
To demonstrate the feasibility of cEM analysis, we compared it with EM/Expa 
analysis by using a simulation study with an artificial metabolic network model and real 
metabolic network analysis by two medium-scale metabolic network model of E. coli and a 
genome scale model for head and neck cancer cells. The cEM analysis greatly reduces the 
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number of EM, computational time and memory cost for the genome-scale metabolic 
network. Application of cEM analysis to Genetic Modification of Flux (GMF)  accurately 
predicts the flux distributions of genetic mutants under particular conditions. Use of cEMs 
analysis, to  plans a genetic engineering strategy for genome-scale metabolic network model 
for producing useful compounds. 
Keywords: Systems biotechnology; Integrating biological data; Constraint-based metabolic 
modeling; Large-scale metabolic network; Elementary mode decomposition; Complementary 
elementary mode  analysis; Quantitative contributions; Prediction speed and accuracy. 
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Chapter 1 
 
Introduction 
 
1.1 Introduction 
 
In the 21st century, next-generation sequencers enabled the human genome to be decoded 
at a surprisingly high speed. Furthermore, the production of biological data has become more 
rapid, owing to the development of systemic high-throughput technology. The crucial 
question has raised how you understand a huge, complicated biological network and ongoing 
challenge is to bridge the gaps in our understanding of processes at the molecular, cellular, 
and tissue levels. It is almost impossible to intuitively understand the behavior of the cellular 
metabolic networks, due to the complexity of the metabolic pathway interactions and large 
number of components are involved in the networks.  
Systems biotechnology is an approach to develop comprehensive and ultimately 
predictive models of how components of a biological system reproduce its observed behavior 
of the metabolic network. Mathematical modeling has been established successfully when 
applied to relatively small-scale systems, while applications to the large-scale models are 
being challenged by the practical advances that generate high-dimensional and high-
throughput data (Waters et al., 2012). The cellular metabolic and regulatory networks are 
often large and complex, the construction and analysis of their computational models are can 
be useful for identifying physiological states and evaluating the effects of network 
perturbations on desired phenotypes. Recently, genome-scale computational models have 
gained increasing prominence and importance; capturing stoichiometric model with 
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thermodynamic constraints have been published for over 30 organisms ranging from 
relatively simple prokaryotes such as Escherichia coli (E. coli) (Milne et al., 2009), to 
complex eukaryotes such as Homo sapiens (Duarte et al., 2007 and Ma et al., 2007; Shlomi et 
al., 2007).   
Metabolomics is a branch of system biology, which has been applied to identify and 
quantize all metabolites in an organism sample under specified living conditions. Strictly 
speaking metabolism refers all metabolites in an organism or cell. Metabolism is essential in 
the processes of life. It is mainly consisted of catabolism and anabolism, anabolism refers the 
process that organisms transfer absorbed nutrients from the external environment into their 
own components and stores the energy; catabolism on the other hand, refers the process that 
organisms decompose itself, produce energy then excrete the end products from the 
decomposition. These processes with the necessary enzymes produce all of the major 
constituents of the cell.  
Metabolic network is an abstract expression of cell metabolism that maps all biochemical 
reactions into a network for a cell or organism, each metabolite is a node and the reactions are 
the links or pathways between metabolites which connect the nodes to form a network. This 
network reflects the interactions between all compounds as well as the enzymes, which 
involved in the metabolic processes. Metabolic network analysis is a successful way of 
predicting the metabolic phenotype of an organism under its metabolic genotype and 
particular conditions which could provide us a better understanding of cellular metabolic 
processes and the evolution of life. Therefore, predicting the functions of a metabolic 
network become one of the most important tasks now days (Ma and Zenf, 2003; Patil and 
Nielsen, 2005 and Wang, 2011). 
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1.2 Reviews of the Literatures 
 
The biochemical reactions which illustrate various portions of the metabolism are 
depicted using a metabolic network. In metabolism, constraint-based metabolic modelling 
methods are systematized biochemical, genetic and genomic knowledge into a mathematical 
framework that enables a mechanistic description of metabolic physiology. Over the 30 years, 
the use of constraint-based approaches have evolved, and an increasing significant number of 
studies have recently combined models with high-throughput data sets for prospective 
experimentation. These studies have demonstrated the endorsement of increasingly important 
and relevant biological predictions (Bordbar et al., 2014). With the growing interest of better 
understandings of the biochemical network, the experimental techniques have improved 
significantly, however, it is still not powerful enough to determine the whole network or too 
expensive to conduct, hence some alternative estimation methods have been proposed by 
metabolic  pathway analysis.  
Constraint-based models have become a fundamental tool to study genome-scale 
metabolic networks (Edwards and Palsson, 2000). Such models use governing constraints to 
restrict potential cellular behavior. The range of all possible behaviors, which is 
mathematically described by the steady-state flux. Constraint-based analyses are used for 
predicting the intracellular metabolic fluxes from the metabolic network map in steady-state 
levels by  integrating of the experimental data from genomics, transcriptomics, proteomics, 
metabolomics, and fluxomics, which are determined by high-throughput technologies. Two 
possible approaches for constraint-based analysis, namely (1) optimization-based and (2) 
pathway-based, when the metabolic network is available, as will be illustrated in chapter 2. 
Several optimizations-based approaches have been developed that allow computing, in the 
altered network, behaviors optimizing a particular network function (Papin et al., 2004). 
Mathematically, this requires are defining a hypothetical objective function.  
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In principle, optimization-based methods can be used to analyze the metabolic 
network and the cellular phenotype of either (1) wild-type or (2) mutant cell. The 
optimization-based analysis methods, e.g., Flux Balance Analysis (FBA) (Fell and Small, 
1986; Varma and Palsson, 1994b), Regulatory-FBA (rFBA) (Covert et al., 2001), 
Minimization Of Metabolic Adjustment (MOMA) (Segre et al., 2002), Regulatory On/Off 
Minimization (ROOM) (Shlomi, et al., 2005), Flux Variability Analysis (FVA) (Mahadevan 
and Schilling, 2003). Optimization-based metabolic analysis with mutant (knock-out, knock-
in) cell is obtained using genetic modification techniques, e.g., OptKnock (Burgard et al., 
2003), RobustKnock (Tepper and Shlomi, 2009), OptReg (Pharkya and Maranas, 2006) 
OptGene (Patil et al., 2005), OptORF (Kim and Reed, 2010) and OptForce (Ranganathan et 
al., 2010). 
The metabolic pathway maps are complex in every living cell, where a coherent set of 
enzymes that catalyzes by various biochemical reactions (Croes et al., 2005; King et al., 2005 
and Zaho et al., 2013). Pathway-based methods are capable of characterizing the entire 
solution space of the possible metabolic network states without imposing the cellular 
objective biological function bias. Metabolic flux analysis (MFA) is used for the quantitative 
estimation of intracellular metabolic fluxes through metabolic pathways and the elucidation 
of cellular physiology in steady-state level (Stephanopoulos, et al., 1998). Pathway-based 
analyses are generally employed a constraint-based modeling approach (Price, et al., 2004), 
e.g., FBA that uses a stoichiometric matrix and an objective function to define a network’s 
allowable solution space. The target metabolic flux capacity is provided by optimizing a 
specific objective function such as cell growth, energy, biomass, adenosine triphosphate 
(ATP) production or metabolite synthesis (Papin et al., 2004; Raman and Chandra, 2009).  
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Metabolic pathway analysis has focused on two approaches, namely, elementary modes 
(EMs) (Schuster et al., 1999) analysis and extreme pathways (Expas) (Schilling  et al., 2000) 
analysis. The EM analysis is potentially effective in integrating  transcriptome or proteome 
data into metabolic network analyses  and a minimal set of reactions that can maintain the 
steady state level, while the Expa analysis is a subset of EM that contains two additional 
conditions and one of them condition to make all Expas systematically independent. The EM 
analysis allows one to systematically enumerate all independent minimal pathways that are 
stoichiometrically and thermodynamically feasible and to offer great opportunities for 
studying functional and structural properties of metabolic pathways (Stelling et al., 2002; 
Schwender et al., 2004; Carlson and Srienc, 2004). The EM-based algorithms, e.g., control 
effective flux (CEF), modified control effective flux (mCEF),   enzyme control flux (ECF) 
and genetic modification of flux (GMF), are very effective in correlating transcriptome or 
proteome data to their associated metabolic network building or flux distributions  and some 
of those augment metabolic network with the gene regulatory network or enzyme activity 
profile (Stelling et al., 2002; Cakir et al., 2007; Kurata et al., 2007; Zhao and Kurata, 2009 a 
b, 2010).  
 
To find the whole set of EMs, distributed memory parallelization and parallel processing 
have been merged together with compression of the stoichiometric matrix (Jevremovic et al., 
2011;  Jevremovic and Boley, 2012) or with the remove of biological infeasible solutions 
(Jungreuthmayer et al., 2013). On the other hand, alternative approaches have been presented 
without enumerate the whole set of EMs (de Figueiredo et al., 2009; Ip et al., 2011; Machado 
et al., 2012). The EM decomposition method (Ip et al., 2011) has been developed to pick up 
the major EMs or linear combinations of EMs, which are responsible for the metabolic flux 
distributions for metabolic networks, while the entire flux distributions must be input for EM 
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decomposition. The EM coefficients (EMCs), which indicate the quantitative contribution of 
their associated EMs and which can be estimated by maximizing a particular objective 
function. The EMs can be described by many possible vector or scalar products of each EM, 
but the predicted fluxes must be consistent with respect to all of them.  
The linear programming (LP) method is often used to predict the metabolic flux 
distribution, where the maximum biomass and specific metabolite formation are selected as 
an objective function (Gayen and Venkatesh, 2006). Such objective functions relate to the 
optimum physiological states, but they are not provided for many organisms. Maximum 
biomass or ATP production are can vary between different organisms and physiological 
conditions. Thus that objective functions are not the best choice. The quadratic programming 
(QP) could optimize EMCs by defining the objective function as the minimal norm of the 
EMCs, but QP has neither a physical nor a biological background and is still restricted to 
relatively small-scale networks (Schwartz and Kanehisa, 2005). A serious problem of QP that 
it depends on the scalar products of each EM. Therefore, the QP method may not be valid for 
optimizing the EMCs (Badsha et al., 2013). The enzyme control flux linear programing 
denoted as ECFLP  (Kurata et al., 2007), which maximizes and minimizes each EMC to 
represent its available ranges in the same manner of the  α-spectrum method (Wiback et al., 
2004), averaging all the estimated EMCs. The ECFLP is practically valuable, but it has 
neither a biological nor a theoretical background.  
To obtain reliable EMCs, the maximum entropy principle (MEP) algorithm (Kurata et al., 
2007; Zhao and Kurata, 2009ab, 2010) have been proposed, which is a universal principle 
established based on Shannon entropy (Shannon, 1948) when insufficient information is 
available. MEP is widely used for flux prediction in particular cases where no biological 
objective function is available and most advantages that it does not depend on the scalar 
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product of each EM. The MEP enthusiastically optimizes hundreds of thousands of the EMCs 
in large-scale networks. 
1.3 Statement of the Problems 
 
The major human diseases like as diabetes, obesity, high blood pressure, cardiovascular 
disease and cancer are involved in failure of human metabolic systems. Therefore, 
metabolism is an important biological process, but these are complex and highly 
interconnected each others. So, it is very important to properly understand the metabolic 
pathway map  in network level. Metabolic network maps are represented by a complex chain 
of chemical reactions and are highly associated between genes, proteins and enzymes; 
consequently mathematical and/or computational approaches are necessary for integration of 
them. Heterogeneous biological data, including genome, transcriptome, proteome, and 
metabolome are integrated into a pathway-based metabolic model to predict a flux 
distribution of genetically modified cells under particular conditions. The integration of 
heterogeneous biological data and model building have become essential activities in 
biological research as technological advancements continue to empower the measurement of 
biological data of increasing diversity and scale. But the challenge becomes how to integrate 
this data to maximize the amount of useful biological information that can be extracted.  
A serious problem arises of EM/Expa analysis is that the computational time increases 
exponentially with an increase in network sizes, which makes the computation of the all 
EMs/Expas expensive and infeasible for large-scale or genome-scale networks (Segre et al., 
2002; Haus et al., 2008; Acuna et al., 2009; Trinh et al., 2009). For example, central 
metabolism of E. coli model, with 112 reactions has more than two million EMs. When 
possible substrates are extended, the number of EMs increases to more than 26 million 
(Terzer and Stelling, 2008). Thus, the huge computation time and memory storage are 
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required to enumerate all the EMs/Expas of large-scale or genome-scale metabolic networks. 
Another problem is that many organisms still do not provide any specific objective biological 
function for estimating the EM coefficients (EMCs) to predict the metabolic flux distribution 
relate to the optimum physiological states. The EMs can be described by different scalar 
products of each EM, but the predicted fluxes must be independent of them. 
1.4 Objectives of the Study  
  
To overcome the aforementioned problems of the existing EM/Expa methods, we develop 
a fast and efficient algorithm, named complementary EM (cEM) analysis, to reduce the 
EMs/Expas (Badsha et al., 2014). To enhance the computing time improvement, we employ 
the EM decomposition method that explores the major EMs or linear combinations of them, 
which are responsible for the metabolic flux distributions. FBA is used to generate many 
possible ranges of metabolic flux distributions as the input data necessary for the EM 
decomposition method. The maximum entropy principle (MEP) is employed as an objective 
function for estimating the coefficients of cEMs to avoid the scalar product problem of EMs. 
To demonstrate the feasibility of cEM analysis, we compared it with EM/Expa analysis by 
using a simulation study with an artificial metabolic network model, and real metabolic 
network analysis by two medium-scale metabolic network model of E. coli and a genome 
scale model for head and neck cancer cells. The cEM analysis greatly reduces the 
computational time and memory cost, without generating a full set of EMs nor any biological 
objective function, which exposing a new window for large-scale metabolic network analysis. 
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1.5 Layout of the Study 
This section contains an overview / structure of the PhD thesis as given below: 
The present chapter provides an introduction, reviews of the literatures, a statement of 
the problems of the study of the existing or ordinary methods, objective of the study to 
overcome those problems and the layout of the PhD thesis. 
In chapter 2, we describe the details about background regarding the heterogeneous 
biological data integration into metabolic networks. To enhance the quality of the thesis, we 
discuss details of the metabolic network analysis for the constraint-based method of 
optimization-based and pathway-based metabolic network analysis, which are used for 
predicting the steady-state intracellular fluxes from the metabolic network by  integrating of 
the experimental data from genomics, transcriptomics, proteomics, metabolomics, and 
fluxomics, those are determined by high-throughput technologies.  
In chapter 3, we discuss  details about the materials and methods of the study. To 
overcome the problems of the existing methods, we introduce a new concept to develop a fast 
and efficient algorithm, complementary EM (cEM) analysis, which is critically useful for the 
integration of heterogeneous biological data into a complex metabolic network map.   
In chapter 4, we will show the results compared with the existing methods by synthetic 
and real metabolic network analysis. To investigate the performance and applicability of the 
cEM method in a comparison of the existing method, we consider a simulation study by an 
artificial metabolic network model and real metabolic network analysis by two medium-scale 
metabolic network model of E. coli and a genome scale model for head and neck cancer cells. 
 
In chapter 5, we give the conclusion and scope of this PhD study, and future research 
interest. 
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Chapter 2 
 
Background 
 
2.1 Introduction 
 
A central challenge in the development of systems biology is the integration of 
heterogeneous biological data into metabolic network model. Mathematical and/or 
computational approaches are  needed to not only integrate this heterogeneous biological data, 
but also use this data to heighten the predictive capabilities of computational models (Blazier 
and Papin, 2012). With the advent of high-throughput technologies, heterogeneous biological 
data types have provided quantitative data for thousands of cellular components across a 
variety of scales. Cellular metabolism is defined as the essential physical and chemical 
processes for the maintenance of life. A metabolic network for a specific organism contains 
all metabolic reactions occurring within the living cells of an organism. With the rapid 
development of genomics and various successful genome projects, biologist deciphered the 
genome sequence of many organisms and the metabolic networks for such organisms can be 
faithfully reconstructed from available genome information. Thus the analysis of metabolic 
network has become essential in further studies, such analysis could help us to achieve a 
better understanding of the topology and biological functions of different organisms, hence 
enable us to utilize cellular metabolic process to assist the development of fermentation 
technology, medical industry and agriculture (Wang, 2011).  
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2.2 Metabolic Engineering 
Metabolic engineering provides clear and insightful information regarding the activity of 
metabolic complex reaction networks from an individual reaction based perspective. 
Metabolic engineering is potentially used for systematic organization and analysis of 
complex metabolic networks (Badsha et al., 2012). The final goal of metabolic engineering is 
to be able to produce valuable substances on an industrial scale in a cost effective manner. In 
the earlier times, to increase the productivity of a desired metabolite, a microorganism was 
genetically modified by chemically induced mutation, and the mutant strain that over-
expressed the desired metabolite was then chosen. However, one of the central problems with 
this technique was that the metabolic pathway affecting the metabolite production was not 
analyzed, and as a result, constraints to production and relevant pathway enzymes to be 
modified were unknown (Voit and Torres 2002).  
In 1990s, a new technique called metabolic engineering emerged to overcome the 
problem of the traditional techniques. Metabolic engineering is emerging the directed 
improvement of product formation or cellular properties through the modification of specific 
biochemical reactions or the introduction of new ones with the use of recombinant 
deoxyribonucleic acid (DNA) technology (Stephanopoulos et al., 1998). The successful 
applications of metabolic engineering are the following some examples, such as, (i) 
Identification of constraints to lysine production in Corynebacterium glutamicum and the 
insertion of some new genes to relieve these constraints to improve production 
(Stephanopoulos et al., 1998). (ii) The engineering of a new fatty acid biosynthesis pathway, 
called reversed beta oxidation pathway which can potentially be catalytically converted to 
chemicals and fuels (Dellomonaco, 2011). (iii) Improved production of 3-deoxy-D-arabino-
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heptulosonate 7-phosphate (DAHP), an aromatic metabolite produced by E. coil that is an 
intermediate in the production of aromatic amino acids (Patnaik and Liao, 1994).     
2.3 Systems Biology 
Systems biology is the study that tries to understand as a system consisting of a biological 
molecule of a large number of organisms. It is an interdisciplinary area which uses 
mathematical and computational models to describe the cellular behavior and phenomena, as 
well as the overall properties of the biological systems in general (Klipp et al., 2009). In the 
study of systems biology, the biological complex is considered as a whole, as divergent to 
studying individual components and interactions. However, this can be a very difficult task 
for the researchers, even for simple bacteria, and to address the difficulty various modeling 
techniques have been proposed approaching the enormous complexity at different levels. A 
wealth of experimentally obtained genomic, transcriptomic, proteomic and metabolomic data 
can be used to model and simulate either the functioning of the entire biological cell or just 
one of its segments (Jevremovic, 2013). One of the attracting aims of systems biology is to 
build-up a mathematical modeling and discover emergent properties, such as, properties of 
cells, tissues and organisms functioning as a system whose theoretical description is only 
possible using mathematical techniques which fall under the concern of systems biology 
(Ahmed, 2008). In the systems biology study, a mathematical or computational approaches 
are necessary to integrate heterogeneous biological data, such as transcriptome, proteome, 
metabolome, and fluxome, to build comprehensive metabolic models. Mathematical models 
are consistently improved or modified by accommodating new  experimental data with the 
current models, enhancing the validation of metabolic networks or the prediction of their 
dynamic behaviors (Wiback, et al., 2004; Borodina and Nielsen, 2005). Generating a new 
knowledge through modelling and integration of experimental data in order to develop a 
holistic understanding of organisms that are studied in systems biology areas. Figure 2.1 
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illustrates the workflow commonly referred to as the systems biology cycle based on Kitano 
(2002a,b). With the growing interest of better understandings of the biochemical networks, 
the experimental techniques were improved significantly, especially by the application to 
biological systems, however, it is still not powerful enough to determine the whole network 
or too expensive to conduct, hence some alternative estimation methods have been proposed. 
Metabolic network analysis successfully predicts the metabolic phenotype which gives us a 
good idea of what is happening in an organism and how the organisms work under different 
external environmental conditions.  
 
Figure 2.1: The systems biology cycle.  
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2.4 Metabolic Networks 
 
Metabolic networks are the study of the complete set of metabolic and physical processes, 
that are determined the physiological and biochemical properties of a cell and these networks 
are comprised the chemical reactions of metabolism, the metabolic pathways, as well as the 
regulatory interactions that guide these reactions. Metabolic network maps are represented by 
a complex chain of chemical reactions and are highly associated between genes, proteins and 
enzymes, which are controlling the fundamental mechanisms that govern the biological 
system. Metabolic and regulatory networks are often large and complex, the construction and 
analysis of their computational models can be useful to identify the structural properties of a 
metabolic network that’s being links the cellular phenotype to the corresponding 
genotype. The phenotype of a biological cell can be studied by means of exploring cellular 
biochemical reactions.  
2.4.1 Glossary 
Metabolism: A small chemical compounds, known as metabolites, can be ingested 
and secreted across the cellular membrane by means of transport reactions. Metabolites are 
the organic compounds that are used in, or created by, the chemical reactions happening in 
every cell of living organisms. This process, known as metabolism, which are responsible for 
breaking down food and other chemicals into energy and materials required for health, 
growth, and reproduction. Metabolism is also responsible for the removal of toxic substances 
from the body. Metabolites can be the starting materials, intermediate materials, or end 
products of these chemical reactions. External metabolites are considered to have defended 
concentrations while internal metabolites have to fulfil a balance condition at steady state. 
 
Substrate and Product:  A molecule called a substrate enters a metabolic pathway 
depending on the needs of the cell and the availability of the substrate. An increase in 
 -26- 
 
concentration of anabolic and catabolic intermediates and/or end-products may influence the 
metabolic rate for that particular pathway. Each single reaction converts one group of 
substrate metabolites into another group of product metabolites and catalyzed by a specific 
enzyme (Schilling et al., 1999; Lacroix et al., 2008; de Figueiredo et al., 2009). The 
connections between biochemical reactions through the substrate and product metabolites are 
created complex metabolic networks that may be analyzed using network theory, 
stoichiometric analysis, and information on protein structure or function and metabolite 
properties (Hatzimanikatis et al., 2004).  
 
Flux:  Each biochemical reaction is controlled or catalyzed by one or more enzymes 
and is characterized by its speed of execution, known as a reaction flux. A reaction in which 
the rate of the forward reaction is always so much higher than the rate of the reverse reaction 
that the latter is relatively negligible. A reaction with metabolites lying on the opposite side 
of a membrane of the cell is considered as an external reaction. Otherwise, a reaction with all 
of its metabolites exclusively lying within the cell boundaries is considered to be an internal 
reaction. The metabolite is considered internal to the network if it is found inside the cell, 
otherwise it is external in which case it is a substrate or product of an external reaction. 
Reaction with metabolites on the opposite side of the cellular or organelle membrane is 
informed as the transport reaction. It is important to note that transport reactions are the 
superset of the external reactions. 
 
Reaction rate: The reaction rate of a certain reaction when the metabolic network is 
in the quasi steady - state. 
 
Steady-state:  The state in which the concentrations of every metabolite does not 
change.  
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Stoichiometric matrix: Matrix containing the stoichiometric constraints for every 
reaction in terms of each chemical reaction. Every row of this matrix represents one unique 
metabolite for a network with m compounds and every column corresponds to one reaction of 
total n, as shown in equation 2.1. The entries in each column are the stoichiometric 
coefficients of the metabolites participating in a reaction. If a metabolite is formed (produced) 
by the reaction, the coefficient has assigned a positive (+) sign, on the other side, if it is 
consumed by the reaction; the stoichiometric coefficient appears with a negative (-) sign. All 
other rows are zero, which means that the corresponding to metabolites that do not participate 
in the reaction networks. Usually, the stoichiometric matrix as denoted by S and defined as 
follows: 
1
2
1 2
11 12 1
21 22 1
1 2
n
n
m m mn
S S S
S S S
S S S
       


   

                 (2.1) 
A simple example of the metabolic network as shown in figure 2.2, where A is the starting 
molecule, B and C are the intermediate metabolites  and D is the product, i.e. the final output. 
Reaction 1, reaction 2 and reaction 3 are controlled or catalyzed by the enzyme 1, enzyme 2 
and enzyme 3, respectively.  
 
 
Figure 2.2: A Simple example of metabolic network 
 
Enzyme 1 Enzyme Enzyme 3 
A B C D 
Reaction 1 Reaction 2 Reaction 3 
Starting 
molecule 
Product 
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2.4.2 Mathematical Representation 
The m n stoichiometry matrix, ,m nS is used to quantitatively represent the 
metabolic network with m internal metabolites and n reactions (Equation 2.1). The element in 
l-th row and i-th column of S represents the amount in moles of the l-th metabolite consumed 
or produced by the i-th reaction. The flux values for all the n reactions in the metabolic 
network are collected into a metabolic flux vector denoted here as 1.nv  Metabolic network 
reactions may be reversible or irreversible, where the flux of every irreversible reaction must 
be non-negative. Hence, an additional thermodynamic constraint must be imposed on the 
elements of the metabolic flux vector corresponding to the irreversible reactions as 
0,iv  where irrevi are indices of the irreversible reactions. For the given stoichiometry 
network, the concentration of m metabolites and their change in time can be described using a 
system of ordinary differential equations as follows: 
1
       for 1,...,
n
l
li i
i
dC S v l m
dt 
                                                                      (2.2) 
Where, lC denotes the concentration of the l-th metabolite in the network.  
The pathway database provides the detailed information about the biochemical 
pathways for a given species of interest. Several databases are developed for the cellular 
enzymes and reactions in the public domain, such as KEGG (Kyoto Encyclopedia of Genes 
and Genomes) (Kanehisa and Goto, 2012; Kanehisa et al., 2012), EcoCyc (Keseler et al., 
2011), MetaCyc (Caspi et al., 2006 and 2008) and HumanCyc (Green et al., 2004). Metabolic 
network reconstructions are important and available for both prokaryotic and eukaryotic 
organisms such as Escherichia coli (Feist et al., 2009), Sacharomyces cerevisiae (Forster et 
al., 2003, Duarte et al., 2004), Haemophilus influenza (Schilling and Palsson, 2000), 
Helicobacter pylori (Schilling et al., 2002; Thiele et al., 2005), Mycoplasma genitalium  
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(Suthers et al., 2009), Staphylococcus aureus (Becker and Palsson, 2005), Homo sapiens 
(Duarte et al., 2007; Thiele et al., 2013) and so on.  
2.4.3 Construction of Stoichiometric Modeling 
 
The stoichiometric models are described a given metabolic network, which can be 
represented mathematically by a stoichiometric matrix, S.  Construction of stoichiometric 
modeling is very important and essential process for further analysis of metabolic network 
model. In the construction of stoichiometric modeling, we consider a simple example of 
metabolic network model as shown in figure 2.3. The procedure for the construction of the 
stoichiometric model of a metabolic pathway network as follows: 
 
Step-1: We obtain a set of pathways or reactions and their stoichiometry from pathway 
databases. Figure 2.3 shows a simple pathway map as an example of stoichiometric modeling. 
The extracellular metabolite substrate uptake Aex into the system A with a flux 1v is converted 
to B and C with flux 2v and 3,v respectively, and metabolites B and C are subsequently 
excreted to product D and E at the respective flux rates 4v and 5.v The reaction formulas are 
also listed in figure 2.3. 
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Figure 2.3: Example pathway of stoichiometric modeling. The dashed line represents the 
inside the system or system boundary, and nodes A, B, and C represent intermediate / 
intracellular metabolites and Aex, D (product 1) and E (product 2) represent extracellular 
metabolites. 
Step-2: Describe the mass balance equation for each intermediate metabolite in the pathway 
mathematically (e.g., A, B, C). 
 
1 2 3
d A
v v v
dt
                                                              (2.3) 
 
2 4
d B
v v
dt
                    (2.4) 
 
3 5
d C
v v
dt
                     (2.5) 
Step-3: Use the steady-state assumption that the time-derivatives of these intermediate 
metabolite concentrations are zero i.e., 
      0d A d B d C
dt dt dt
                       (2.6) 
1
2
3
4
5
Reactions
: (Substrate)
:
:
: (product 1)
: (product 2)
exv A A
v A B
v A C
v B D
v C E





Inside the system /  
System boundary 
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Then, we can write  the following equations from step-2, by using equation 2.6 as follows: 
1 2 3 0v v v                                           (2.7) 
2 4 0v v                                            (2.8) 
3 5 0v v                                            (2.9) 
Step-4: Thus, the mass balance equations can be described by a matrix form as follows: 
1
2
3
4
5
                     
[ ] 1 -1 -1  0  0
[ ] 0  1  0 -1  0 0
[ ] 0   0  1   0 -1
Stoichiometric matrix (S) Flux vector (v)
v
vd A dt
vd B dt
vd A dt
v
                  
 
                       (2.10) 
Finally, we can write the mass - balance equation mathematically as follows: 
0 S v                   (2.11) 
 
2.5 Constraint-Based Metabolic Network Analysis 
 
Constraint-based metabolic network analysis are the promising tools for the study of 
metabolic networks, as they do not require detailed knowledge of the biochemical reactions. 
Some of the methods only need information about the stoichiometric coefficients of the 
reactions and their reversibility types, i.e., constraints for steady-state conditions (Marashi et 
al., 2011). The traditional approach to metabolic modelling is to describe the components of a 
model in such detail that the model correctly represents the phenotype, then the constraint-
based approach is rather to impose increasingly detailed constraints on the solution space so 
v1 v2 v3 v4 v5 
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that only relevant phenotypes are feasible. There are many applications and situations of 
interest, it may be assumed that the concentration of the metabolites internal to the metabolic 
network is constant in time (Clarke, 1988; Covert et al., 2003; Park et al., 2009). Which 
implies that the for every internal metabolite, the amount being produced is equal to the 
amount being consumed by the participating reactions. According to this condition, we can 
be imposed on the metabolic network as defined following two constraints as follows: 
1. Pseudo steady-state:  Internal metabolites are not accumulating within the metabolic 
network. In other words, the amount of metabolite being produced equals the amount 
being consumed. 
1
=0       for 1,...,
n
li i
i
S v l m

                                                        (2.12) 
2. Feasibility:  v 0 ,      if   i i irrev  where irrev is a set of indices of irreversible 
reaction, i.e. the flux is non-negative for irreversible reaction. 
These constraints are fundamental and used during the process of the reconstruction of the 
genome-scale metabolic network model. If the reconstructed metabolic network models are 
available, there may be two possible approaches for its analysis will be described in a next 
section, namely, (1) optimization-based and (2) pathway-based. 
2.5.1 Optimization-based Analysis Methods 
At quasi-steady state and the reaction thermodynamics, evolutionary nature and goals 
of the biological cell may be included when the constraints imposed on the metabolic 
network. Particularly the case for the biological cells of microorganisms, such as various 
bacteria and fungi, as well in some other cell types in eukaryotes which strive to optimize the 
biomass function, cellular growth, or in some cases energy production (ATP). The 
maximization of the cellular growth and its respective biomass reaction is an adaptive 
evolutionary nature of the biological cell. Biomass reaction is an artificial reaction added to 
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the metabolic network model and it assures that all of the metabolites necessary for the 
cellular growth are present in an experimentally determined proportion (Feist and Palsson, 
2010). It is important to mention that while the cellular growth may be adopted as a valid 
optimization objective function to optimize its metabolic network flux distribution dictated 
by some other biological goal. Therefore, the metabolic network can be analyzed with an 
appropriately selected cellular objective and under the given constraints  using various linear 
and non-linear optimization methods (Zomorrodi  et al., 2012). To analyze the metabolic 
network and the cellular phenotype by the optimization-based methods can be used on either 
(1) wild-type or (2) mutant-type cell. Mutant cell is obtained using genetic modification 
techniques such as knock-out, knock-in or over-expression of the genes, which are 
responsible for the reactions in the metabolic network. In illustration of the methods, it will 
be assumed that the metabolic network is given with its stoichiometry matrix ,m nS and the 
corresponding flux vector with 1.nv v In the case when wild-type cell flux vector is 
contrasted with the mutant cell flux vector, the notation 
 wtv and  mutv will be used, 
respectively. 
2.5.1.1 Flux Balance Analysis 
Flux balance analysis (FBA) is an optimization-based approach that used to predict 
the quasi- or steady-state metabolic fluxes by applying mass balance constraints and objective 
functions (Fell and Small, 1986; Varma and Palsson 1994a,b; Kauffman et al., 2003; Lee et 
al., 2006; Feist and Palsson, 2010; Raman and Chandra, 2009; Orth et al., 2010). FBA is a 
constraint-based mathematical method that predicts the internal fluxes of large-scale 
metabolic networks, without requiring the biochemical knowledge of the network such as 
concentration of metabolites or enzyme kinetics of the system that make it easy to implement. 
Maximization of the biomass function or ATP production is frequently used as an objective 
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function for predicting the metabolic fluxes in the exponential growth phase (Van and 
Heijnen, 1995). We can evaluate the maximum yield of the specific compound using 
maximization of the target production rate as the objective function. Because FBA can be 
performed from the network information alone and without the enzyme kinetics, many FBA 
studies use genome-scale metabolic pathways rather than a small pathway alone, such as the 
central carbon metabolism pathway. A stoichiometric modeling is first constructed, as in the 
general form of MFA (details in section 2.5.2.1), to predict the metabolic flux distributions 
using FBA. FBA is particularly useful when the metabolic network system is under-
determined (details of the degrees of freedom and system are  in section 2.5.2.1). The 
solution space of an under-determined system  is then limited by the addition of constraints, 
such as the upper or lower limits of each flux, and a unique flux distribution is then predicted 
by applying an objective function.  
In FBA, generally a linear objective function is used, the metabolic flux distribution 
that maximizes or minimizes the objective value can be solved by the following linear 
programming (LP) as follows. 
1
1
maximize Z .
subject to . 0 ;
n T
i i
i
n lb ub
li i i i i
i
c v
v v v v



  

S                                             (2.13)
 
Where, ic is a weight coefficient for flux iv and the superscripts lb and ub  represent lower 
and upper limits, respectively. The overview of FBA is shown in figure 2.4. Gene regulatory 
network information was integrated with the metabolic network to result in the methods such 
as regulatory FBA (rFBA) (Covert et al., 2001; Covert and Palsson, 2002, 2003), steady-state 
regulatory FBA (SR-FBA) (Shlomi et al., 2005). 
Although FBA is an influential method of solving under-determined systems, but the 
choice of an appropriate objective function can be biased and requires careful consideration. 
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Thus the objective function are not the best choice. While the maximization of biomass yield 
is frequently used as the objective function in many studies, it is not certain whether a single 
objective function can be universally applicable, especially for gene knockout mutants (Toya 
et al., 2010). To solve this problem, advanced methods have been proposed such as MOMA 
(Segre et al., 2002), ROOM (Shlomi et al., 2005), FVA (Mahadevan and Schilling, 2003), 
OptKnock (Burgard et al., 2003), RobustKnock (Tepper and Shlomi, 2009), OptReg (Pharkya 
and Maranas, 2006), OptORF (Kim and Reed, 2010), OptForce (Ranganathan et al., 2010).   
 
 
Figure 2.4: Overview of flux balance analysis (FBA) 
 
2.5.1.2 Regulatory-Flux Balance Analysis 
FBA has been used successfully to predict the time course of growth and by-product 
secretion, the effects of mutation and knockouts, and gene expression profiles. However, 
FBA leads to incorrect predictions in situations where regulatory effects are a dominant 
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influence on the behavior of the organism. FBA has not accounted for the constraints 
associated with regulation of gene expression nor activity of the expressed gene product. 
Therefore, regulatory-FBA (rFBA) has been proposed to include regulatory events within 
FBA to broaden its scope and predictive capabilities (Covert et al., 2001). Where, the 
transcriptional regulatory events represent as time-dependent constraints on the capabilities of 
a reconstructed metabolic network to further constrain the space of possible network function. 
Information of gene expression is incorporated by the Boolean logic formalism that uses a 
binary system, where the flux of one reaction is set to be zero if the relative gene is not 
expressed. The flux distribution of such gene knockout mutants could be optimized by LP 
under the additional constraint. 
2.5.1.3 Minimization Of Metabolic Adjustment 
 
Minimization of metabolic adjustment (MOMA) employs the quadratic programming 
(QP) to recognize a point in metabolic flux space, which is closest to the wild-type cell, 
compatible with the gene deletion constraint (Segre et al., 2002). The mutant cell would 
strive to minimize its overall flux distribution   mutv deviation from the flux distribution in 
the wild-type cell   ,wtv when a subset of reaction knockouts was performed in a cell. In 
MOMA, the flux distributions of gene knockout mutants can be estimated by the QP-based 
minimization of the Euclidian distance from those of wild type to those of a mutant as 
following problem: 
    
 
 
2
1
minimize Z
subject to 0                                                                                         (2.14)
0,      where  is a set of indices of deleted reacti
n wt mut
i
mut
mut
h
v v
v
v h KO KO

 
 
 

S
ons.
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2.5.1.4 Regulatory On/Off Minimization 
 
Regulatory on/off minimization (ROOM) uses mixed integer linear programming 
(MILP) to predict the metabolic flux distributions of gene deletion mutants in which the 
number of significant flux changes is minimized compared with wild type (Shlomi et al., 
2005). The ROOM is motivated by two assumptions that (1) genetic regulatory changes 
required by flux changes after the reactions are knocked out are minimized by the cell in 
order to minimize the adaptation cost and (2) regulatory changes can be described using 
Boolean on/off dynamics which assigns fixed cost to each regulatory change irrespective of 
its magnitude. The MILP problem as follows: 
   
 
 
 
     
1
min, max,
max, , ,
minimize Z
subject to 0
                     
0,      
                                                                    (2.15
n
i
i
mut
mut
i i
mut
h
mut wt wt
i ii i u i u
y
v
v v v
v h KO
v y v v v


 
 
 
     

S
     
 
     
     
min, , ,
,
,
)
                       
                        0,1
                        
                         
                         
mut wt wt
i ii i l i l
i
wt wt wt
i u i i
wt wt wt
i u i i
v y v v v
y
v v v
v v v
 
 
     

  
  
    1,..., \i n KO  
The flux vectors  wtv and  mutv are flux distributions of the wild-type and mutant metabolic 
networks, respectively. Flux interval    ;wt wtulv v    determines the local interval around the 
wild-type point. This local interval is determined using user specified parameters γ and ζ . 
Objective function, a sum of binary variables ,iy  minimizes the number of unconstrained 
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reaction fluxes which can significantly deviate from their corresponding flux values in the 
wild-type metabolic network. If 1iy  which leads to no additional constraints on the flux 
 
.
mut
iv On the other side, if 0iy  the reaction 
 mut
iv cannot significantly deviate from its 
respective wild-type value 
 
.
wt
iv One of the disadvantages of this method is the need to 
specify the parameters γ and ζ. 
 
2.5.1.5 Flux Variability Analysis 
 
Flux variability analysis (FVA) is often used to determine the robustness of metabolic 
models in various simulated conditions (Mahadevan and Schilling, 2003; Gudmundsson and  
Thiele, 2011). The optimal value of the given cellular objective (e.g. Biomass) often used in 
different flux distributions in the metabolic network analysis. If a maximal biomass flux is 
computed  maxv ,biomass it may then be appended as an equality constraint across multiple linear 
programs which all aim to determine a possible flux range of remaining reactions as follows: 
 
max,
min, max,
max/min       v             for 1,...,
subject to 0
                        
i
biomass biomass
h h h
i n
v v
v v v h i

 

  
S v
                                           (2.16) 
2.5.1.6 OptKnock 
 
The principal challenge in biotechnology  is the systematic development of 
engineered microbial strains for optimizing the production of biochemical or chemicals 
(Stephanopoulos et al., 1998). However, the product yields of many microorganisms are often 
far below their theoretical maximums, when the absence of metabolic and genetic 
engineering interventions. OptKnock framework is developed a bi-level optimization for 
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suggesting gene knockout strategies for biochemical overproduction while recognizing  that 
metabolic flux distributions are governed by internal cellular objectives (Burgard et al., 2003; 
Pharkya et al., 2003). The framework of  OptKnock in the form of a bi-level MILP problem 
as follows: 
 
 
 
   
max
max,
min
max        v            
subject to      v
     subject to v 0
                                        v  v
                                         v
mut
chemicaly
mut
biomassv
mut
mut wt
biomass biomass
 

S
 
 
 
, max,
1
v  v
                        y 0,1
                        1 y
mut
i i i ii
i
n
i
i
y y
K

   

 
                                    (2.17) 
Parameter η (usually =0.05-0.1) determines the required minimum flux which the biomass 
reaction should carry as a fraction of the maximum possible value  max,v wt biomass    in the wild 
type strain. The bi-level MILP problem (Equation 2.17) can be transformed into a one-level 
MILP and then solved using appropriate solver. The number of reaction deletions is 
constrained with the parameter K, where 0iy   denotes the inactivated reaction. 
2.5.1.7 RobustKnock 
 
A major disadvantage of the OptKnock framework was the existence of competing 
pathways with uncoupled production of the chemical with biomass. The OptKnock do not 
estimate for the presence of competing pathways in a metabolic network that may diverge 
metabolic flux away from producing a required chemical, resulting in lower or even zero 
chemical production rates in reality making these methods slightly over optimistic. This 
problem was addressed in a modified version of OptKnock, called RobustKnock, that 
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accounting for the presence of competing pathways in the network by predicting gene 
deletion strategies that lead to the over-production of chemicals of interest (Tepper and 
Shlomi, 2009). The framework of RobustKnock is formulated by a bi-level maximum-
minimum optimization problem that underlies is the following form:  
 
 
 
   
max min
max
max,
                   v            
subject to      v
     subject to v 0
                                        v  v
                             
mut
chemicalvy
mut
biomassv
mut
mut wt
biomass biomass
 

S
 
 
 
min, max,
1
            v v  v
                        y 0,1
                        1 y
mut
i i i ii
i
n
i
i
y y
K

   

 
                                    (2.18) 
Similarly as in OptKnock, the outer max-min problem searches for the reaction knockout 
subset of the size not larger than K, while the inner problem is the flux balance analysis 
which optimizes biomass flux for the given knockout combination. 
 
2.5.1.8 OptReg 
 
The OptReg framework was proposed to allow knockout, over-expression and under-
expression of reactions in a metabolic network (Pharkya and Maranas, 2006). The allowed 
flux value range min, max,,i iv v   can be easily determined, but the interval    max,min, ,wt wt iiv v     
corresponding to the wild-type flux value range requires experimental measurements. The 
above both interval are determined the optimization problem that underlies OptReg is 
formulated as follows: 
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Where, C is the regulation strength parameter in the interval [0; 1] and determines the 
fraction of the range to which down-regulated and up-regulated flux belongs. Parameter K is 
the maximal number of reactions which can be modified (deleted, up-regulated, down-
regulated) and ϕ has a value determined through a trial-and-error process. 
 
2.5.1.9 OptORF 
 
The computational designs based on reaction deletions can sometimes result in 
strategies that are genetically complicated or infeasible, due to the presence of multi-
functional enzymes and isozymes. Furthermore, due to regulatory restrictions the strains 
might not be able to grow initially. To address such aforementioned limitations, a new 
approach has developed for identifying metabolic engineering strategies based on gene 
deletion and over-expression, namely, OptORF (Kim and Reed, 2010). The OptORF is a bi-
level optimization framework, which extends OptKnock to incorporate the GER (gene-
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enzyme-reaction) associations. The framework of OptORF has outlined the following 
optimization problem as defined in equation 2.20.  
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where the GER is a three-dimensional array consists of binary variables representing the 
reaction   ,id enzyme   ,nb and gene  .gy These binary variables denote if gene g is 
expressed, so that the enzyme n is active inducing a non-zero flux in the reaction i. Denote 
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with GERJ a set of indices i of reactions which appear as triplets in GER,  N i be a set of 
indices n of enzymes, which are associated with reaction i in GER, and  G n be a set of 
indices of genes g which are associated with the enzyme n in GER. While accounting for 
GER associations, one may step in further to look at the metabolic and transcription factor 
genes with respective sets METG and .TFG For the expression of the gene m, here indicated 
using the binary variable ,ma can be influenced by activator or repressor r, denoted here 
using the binary variable .rx Sets of activators and repressors which may influence condition 
m for the expression of one or more genes are denoted  ActR m and   ,RepR m respectively. 
Binary variables gz and gw denote if the gene g was deleted or over-expressed, allowing no 
more than 1K deletions and 2K over-expressions in the cell.  
2.5.1.10 OptForce 
 
The OptForce has been proposed to identify all the possible engineering interventions 
by categorizing reactions in the metabolic network model, which is depending upon whether 
their metabolic flux values are increase, decrease or become equivalent to zero to meet a pre-
specified overproduction target (Ranganathan et al., 2010). The framework of OptForce 
mainly follows two steps as given below: 
Step-1: Identifying flux range of reactions for the wild-type strain. Solving 2q linear 
Problems as follows: 
 
 
   
max,
min, max,
exp exp
max,min,
max/min       v             for 1,...,
subject to 0
                        1,..., \ 
                      
i
biomass biomass
i i i
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i n
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v v v i E
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 

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   
S v
                                     (2.21) 
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It is assumed that it was possible to obtain an experimental flux range for the subset of 
reactions indexed by elements of the subset in E 
Step-2: Identifying flux range of reactions for the over-producing (mutant) strain. Similarly 
as in previous step 2q linear problems as follows: 
 
 
 
 
max
max
min, max,
max/min       v             for 1,...,
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                        1,..., \ 
                    
i
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i i i
i n
v v
v v
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

 


   
S v
                                     (2.22)
 
2.5.2  Pathway-based Analysis Methods 
 
Metabolic pathways are the complex chain of biochemical reactions that occurring 
within a cell and increasingly promising in evaluating inherent network properties in the 
biochemical reaction network model. Metabolic pathway analysis becomes a core method for 
constructing a mathematical model that predicts the metabolic flux distribution for large-scale 
metabolic networks. Pathway-based analysis considers only the two constraints given in the 
section 2.5, without the specifying the cellular objective function that used in the 
optimization-based methods. Pathway-based analysis emerges for constructing a 
mathematical or computational model that accesses of functional and structural the properties 
of metabolic networks. Pathway-based methods are capable of characterizing the entire 
solution space of the possible metabolic network states without imposing the cellular 
objective bias. Optimization-based methods are guided by the cellular objective, and capable 
of exploring only a portion of the entire solution space. Metabolic pathway solution space can 
be confined using an algorithm for the enumeration of extreme rays in the bounded 
polyhedron where the bounded polyhedron corresponds to the degenerate polytope as will be 
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illustrated in more details in the upcoming subsection. Stoichiometries modeling is an 
essential process for the study of metabolic networks by the pathway-based analysis method.  
2.5.2.1 Metabolic Flux Analysis 
 
Metabolic flux analysis (MFA) is a powerful and essential tool for the determination 
of metabolic pathway fluxes. In this method, the intracellular metabolic fluxes are calculated 
by using a stoichiometric model for the major intracellular reactions and applying a mass 
balance condition around the intracellular metabolites.  The implementation of the MFA, a 
set of measured metabolic fluxes are required in addition to the stoichiometric model. Usually, 
the input and output fluxes of the metabolic network are measured as specific rates by the 
experimental study. One of the strongest advantages of the MFA over other simulation 
methods is that, the stoichiometric model and the input and output fluxes are the only 
requirement for the input of MFA (Toya et al., 2011). We describe the processes used for the 
calculation of MFA using the simple example pathway as shown in figure 2.2. The mass 
balance equation for intracellular metabolites A, B and C can be written as the following 
matrix form as follows:  
1
2
3
4
5
1 -1 -1  0  0
0 1 0 -1   0 0 0                            (2.23)
0 0   1  0 -1
v
vA
d vB v
dt
vC
v
                               
S  
Where, S is the stoichiometric matrix and v is the reaction vector or flux vector. In the case, 
1v and 4v are measurable (known) in the intracellular metabolites A, B and C, the 
stoichiometric matrix can be separated into known and unknown parts as follows: 
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2
1
3
4
5
1 0 -1 -1 0
0 -1 1 0 0 0         (2.24)
0 0 0 1 -1
v
v
v
v
v
                            
 
Multiplying by the inverse of the unknown part of the stoichiometric matrix on both sides of 
the equation and moving the known part to the right side of the equation, the unknown fluxes 
2 3 5( ,  and )v v v can be expressed as a function of the measurable (known) fluxes 1 4(  and )v v  
as follows: 
1
2
1
3
4
-1 -1 0 1 0
1 0 0 0 -1 (2.25)
5 0 1 0 0 0
v
v
v
v
v
                      
    
 
In principle, the unknown flux vector can be solved using the stoichiometry and the 
known measurable fluxes. We need to consider the degrees of freedom of the network before 
actually solving the problem for the fluxes, (Stephanopoulos et al., 1998). The degrees of 
freedom are the number of independent fluxes and is calculated as the following equation as 
follows: 
d n k nd                                                                           (2.26) 
 
Where, d is the degrees of freedom, n is the number of fluxes, k is the number of constraints, 
and nd is the number of measurable or determined fluxes. The system is called a “determined 
system”  if the number of degrees of freedom is 0, then the fluxes are determined as a unique 
solution by the intersection of the lines which represent constraints. Moreover, the system is 
an “over-determined system” if the number of degrees of freedom is less than 0, then the 
minimum norm and least-squares solution can be calculated using the Moore-Penrose pseudo 
inverse method (Penrose, 1955 and Stephanopoulos et al., 1998). Conversely, the system is 
an “under-determined system” if the number of degrees of freedom is greater than 0, then 
immense solutions exist because of the lack of constraints. The relationship between the 
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network system and the number of degrees of freedom as shown in figure 2.5. We can 
determine the unknown metabolic fluxes are using MFA quite easily for  determining or 
over-determined system. Under-determined systems require more constraints to reach a 
particular restricted solution. The primary challenge in the use of MFA is that most of the 
biological networks are under-determined systems.  
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Figure 2.5. Relationship between the number of degrees of freedom and the system. 
2.5.2.2 Elementary Mode Analysis 
Elementary mode (EM) analysis (Schuster and Hilgetag 1994) is one of the most 
popular and essential techniques in a metabolic pathway analysis of metabolic networks. The 
EM analysis is potentially effective for integrating transcriptome or proteome data into 
metabolic network and which is exploring the mechanism of how phenotypic or metabolic 
flux distributions are changed with respect to environmental and genetic perturbations (Zhao 
and Kurata, 2010). A quantitative measure of metabolic fluxes is carried by individual EMs, 
 
Degrees of freedom is defined as:
:  The number of fluxes
k: The number of constraints
: The number of measurablefluxes
d n k nd
n
nd
    
Example network 
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which is of great opportunity to identify dominant metabolic processes, and to understand 
how these processes are redistributed in biological cells in response to the changes in 
environmental conditions, enzyme kinetics, or chemical concentrations.  
Generally, the biological networks can be represented by a stoichiometric matrix S, 
for the interconnectivity of metabolites within a network of biochemical reactions. The rows 
of S represent to the metabolites (m) and the columns of S represent to the reactions (n) in a 
network, with elements corresponding to stoichiometric coefficients of the associated 
reactions. The coefficient of S has a positive (+) sign, if a metabolite is formed (produced) by 
the reaction and the stoichiometric coefficient appears with a negative (-) sign, if it is 
consumed by the reaction. All other rows are zero  if the corresponding metabolites that do 
not participate in the reaction. At the steady-state, the mass balance equation is given by the 
following form as follows:  
0, S v                                                                                                                                          (2.27) 
where 1 2( , ,..., )
t
nv v vv is the vector whose elements corresponds to metabolic fluxes and n 
is the number of reactions. The sets of basis vectors are determined by the all possible 
solution set of the equation (2.27). The EM matrix P is uniquely determined using the 
stoichiometric matrix and the flux vector, as follows: 
, v P λ                  (2.28) 
where 1 2( , ,..., )
t
ne  λ  is the EMC vector and ne is the number of EMs. The components 
of these vectors and matrix are defined as the following form as follows: 
          
1 11 12 1 1
2 21 22 2 2
1 2
    
m
m
n n n nne ne
v e e e
v e e e
v e e e



                              


     

                                                                  (2.29) 
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 The j-th column for the P matrix is the j-th EM vector: 1 2( , ,..., ) .
t
j j j nje e e e The flux 
distribution can be also represented as superposition of the EM vectors with non-negative 
EMCs as follows: 
         
1
  
ne
j j
j
 v λ e                                                                                                        (2.30)        
The EMs fulfills the following three conditions as given below: 
1. Pseudo steady-state:  0, S v i.e. The intermediate or intracellular metabolite 
concentrations remain constant in the metabolic network model.  
2. Feasibility / Thermodynamics: 0, i v if the i-th reaction is irreversible. 
3. Non-decomposability / elementary: There is no other vector like, w (w ≠ v and w 
≠ 0), which is fulfilling the conditions 1 and 2, such that the set of indices of the non-
zero elements in w is a strictly proper subset of the set of indices of the non-zero 
elements in v. 
The Expa or cEM analyses were performed in the same manner as EM analysis, where the 
Expas or cEMs are employed instead of the EMs in equations (2.28, 2.29, 2.30). Details of 
the cEM analysis will be described in the materials and method section. 
 
The EM analysis is a powerful metabolic pathway analysis tool to recognize the 
structure of a metabolic network. The EM analysis can decompose the complicated metabolic 
network by comprising of highly interconnected reactions into uniquely organized pathways. 
These pathways, consisting of a minimal set of enzymes that can operate at the steady-state 
condition of  the cellular metabolism, which represent the independent cellular physiological 
states (Trinh et al., 2009). However, EM analysis does not decompose the reversible reactions 
into two irreversible reactions in calculating EMs and introduces a systematic way of 
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extracting biologically meaningful pathways from an intricate metabolic network. In this 
context, an alternative approach has been proposed, called, extreme pathway analysis (Expa) 
(Schilling et al., 2000). 
2.5.2.3 Extreme Pathways Analysis 
 
The extreme pathway (Expa) analysis is closely related to EM analysis because Expas are 
a subset of EMs. The Expa analysis can be measured as a mixture between stoichiometric 
model and EM analysis. The only internal reversible reaction is split into two irreversible 
reactions for computing of Expas, while it does not decompose reversible exchange reaction 
(Trinh et al., 2009). Different from EM analysis, Expa analysis contains two additional 
constraints, one of them to make all Expas systematically independent (Schilling et al., 2000). 
The metabolic flux vector can be expressed as a nonnegative linear combination of Expas or 
EMs in metabolic reaction networks. The Expas are the systematically independent subset of 
EMs; that is, one Expas can not be expressed as a nonnegative linear combination of any 
other Expas. The two additional conditions for Expa with EM as follows:   
4. Network reconfiguration: Define exchange and internal reaction, all reversible 
reactions split into pairs (forward and backward direction) of  irreversible reactions.  
5. Systemic independence:  The Expas are the systematically independent subset of 
EMs; that is, no Expas can be expressed as a nonnegative linear combination of any 
other Expas. 
Note that, if the reactions, including both internal and exchange reactions are irreversible 
in metabolic networks, then the two sets EMs and Expas are identical or equivalent. On the 
other hand, if the exchange fluxes are all reversible, there is more EMs than Expas. Therefore, 
the identification of Expas depends on the metabolic network reconfiguration, while the 
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identification of EMs does not. For illustration, Expas identified in a metabolic network 
whose reversible exchange reactions split into two irreversible reactions may not be Expas to 
any further extent in the original metabolic networks whose reversible exchange reactions do 
not split (Klamt and Stelling 2003). The basic difference between EM and Expa analyses are 
illustrated in figure 2.6.  
 
Figure 2.6: Difference between EM and Expa analyses. (A) Reaction network, (B) EM and 
(C) Expa analyses. 
2.5.2.4 Control Effective Flux 
 
The control effective flux (CEF) is an EM-based algorithm that has been developed to 
predict the transcriptional regulations, e.g. the gene expression patterns of E. coli (Stelling et 
al., 2002) and Saccharomyces cerevisiae (Cakir et al., 2004, 2007) grown on different 
Reaction network 
System boundary 
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substrates. The CEF algorithm was developed to estimate the change in transcriptional 
regulations based on the topology of metabolic networks with specific biological reactions, 
when the substrate changes, e.g. from glucose to acetate, ethanol or glycerol (Cakir et al., 
2004, 2007; Stelling et al., 2002). The efficiency of an EM corresponding to the specific 
biological function is denoted by, ,SPEOBJ.j  The ratio of the EM output those reactions are 
involving the objective function to the investment required to form each EM, i.e. the sum of 
the absolute elements in the EM is defined as follows: 
 SPEOBJ,
,SPEOBJ
,
,jj
i j
i
P
P
                 (2.31) 
where ,i jP  is the i-th reaction in the j-th EM of the normalized element and SPEOBJ is the 
related reaction number for the specific biological function, e.g., biomass production and 
ATP yield. The CEF is represented by the weighted sum of the i-th elements of the all EMs 
using their associated efficiency ,SPEOBJj for the i-th reaction as follows: 
  ,SPEOBJ ,
max  ,SPEOBJSPEOBJ SPEOBJ
1CEF ,
j i j
j
i
j
j
P
P





             (2.32) 
where maxSPEOBJP is the maximum element in the row of biological function. To assess the 
validity of the CEF metrics, the transcription ratio for the i-th reaction under different 
substrate conditions, S1 and S2, is defined by: 
    21 2 1
CEF
,
CEF
i
i
i
S
S S
S
                 (2.33) 
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2.5.2.5 Modified Control Effective Flux 
 
The modified CEF algorithm (mCEF) is necessary to apply CEF to a broad range of 
genetic mutants that over-express, under-express or lack a metabolic gene (Zaho and Kurata, 
2009b). The efficiency of for such a genetic mutant for the j-th EM is defined by: 
  SPEOBJ,,SPEOBJ ,
EA
EAP      if reaction  is modified
1           otherwise 
j jm
j
i j i
i
i
i
P
P
i
 

 
 

                (2.34) 
Where EAPi  is the enzyme activity parameter for the relative gene expression, i.e. enzyme 
activity, responsible for the i-th reaction of a mutant to wild type. When EAP 0,i   if the 
gene of the i-th reaction is deleted. If EAPi >1 or <1 then it is over- or underexpressed, 
respectively. The i , is the adjustment factor for calculating the investment for genetic 
mutants. EA j  is the adjustment factor that incorporates the change in the modified reaction 
into each EMs output, as defined by:  
,
1
,
,
,
EA ge
EPA    if 0
ge
1           if 0 
n
j i j
i
i i j
i j
i j
P
P


  

                                (2.35) 
Where, ,gei j  is the parameter demonstrating the gene expression state of the i-th reaction in 
the j-th EM. The numerator of the equation (2.34) is  increasing or decreasing, if a gene 
within an EM is over-expressed or under-expressed respectively. For EPA 0,i  the EM 
containing it is neglected ( ,SPEOBJ 0
m
j  ), which is consistent with the EM analysis of gene 
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deletion mutants. When EPA 1,i  i.e. If gene expressions are not changed at all, then the 
equation (2.34) and equation (2.31) is consistent. Equation (2.34) is an extension of the 
original efficiency [Equation (2.31)] to genetic mutants. The mCEF for the mutant is defined 
as follows: 
 
, ,SPEOBJ
max
SPEOBJ SPEOBJ  ,SPEOBJ
1mCEF
m
i j ijj
i m
jj
P
mut
P
 

    

               (2.36) 
The mCEF for wild type is the original of ECF as follows:  
 
 ,SPEOBJ ,
max ,SPEOBJSPEOBJ SPEOBJ
1mCEF
j i j
j
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j
j
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The mECF of the relative change in a gene expression profile of a mutant to wild type is 
provided by: 
    
mCEF
,
mCEF
i
i
i
mut
wt mut
wt
                (2.38) 
2.5.2.6 Enzyme Control Flux 
 
The EM-based algorithm, enzyme control flux (ECF) has been proposed (Kurata et al., 
2007) to link enzyme activity data to flux distributions of metabolic networks that integrates 
enzyme activity into EM analysis. The ECF is describing how changes in enzyme activities 
between the wild-type and a mutant-type are related to changes in the EMCs by presents the 
power-law formula. The ECF have been validated by the  integrated enzyme activity data into 
the EMCs of E. coli and Bacillus subtilis wild-type (Kurata et al., 2007). The ECF model 
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successfully uses an enzyme activity profile to estimate the flux distribution of the mutants 
and the increase in the number of incorporating enzyme activities decreases the model error 
of ECF (Kurata et al., 2007). 
The EMCs of wild type  1 1, ,..., twt wt wt wtm     are calculated from the flux 
distribution of the wild type by the optimization problem of QP (Schwartz and Kanehisa, 
2005, 2006) as follows: 
 2     min     
subject to P
                0.
wt
j
j
wt
wt
j
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 


               (2.39) 
Then the EMCs of a mutant are provided by the following form as follows: 
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                        (2.40) 
Where, EMC vector of a mutant type,  1 1, ,..., ,tmut mut mut mutm    ,i ja  is the 
relative enzyme activity for the i-th reaction in the j-th EM of a mutant to wild type, ia is the 
enzyme activity ratio for the i-th reaction of the mutant to wild type. β is the factor use for the 
normalized, so that the substrate uptake flux is the same as that of wild type. The flux 
distribution of the mutant type is provided by the following form as follows:  
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mut mutv P                   (2.41) 
 
2.5.2.7 Genetic Modification of Flux 
 
The critical technologies used for designing or improving the metabolic flux 
distribution of microbes by the gene deletion and over-expression. There are many algorithms 
already have been developed to predict a flux distribution from a stoichiometric matrix in the 
mutants in which some metabolic genes are deleted or non-functional, but there are few 
algorithms that predict how a broad range of genetic modifications, such as over- and under-
expression of metabolic genes, alters the phenotypes of the mutants at the metabolic flux 
level. Genetic modification of flux (GMF) (Zhao and Kurata, 2009b) has been proposed to 
overcome such problem, which couples, two algorithms modified control effective flux 
(mCEF) and enzyme control flux (ECF). A flow chart of the GMF algorithm is depicted as 
shown in Figure 2.7. GMF is an EM-based algorithm that integrates gene expression or 
enzyme activity data to predict the flux distributions. The GMF algorithms not only used to 
predict the flux distribution of a gene deletion mutant, but also the mutants with under-
expressed and overexpressed genes in E. coli and Corynebacterium glutamicum (Zhao and 
Kurata, 2009b). 
The CEF ratios of a mutant to wild type are calculated from the metabolic network topology 
by the mCEF algorithm that are presented in earlier sections. Assume that enzyme activity 
profile is linearly correlated to its associated  gene expression profile, the EMCs are 
calculated of a mutant cells from the flux distribution of the wild type optimization problem 
by QP [Equation (2.39)]. There is a quantitative correlation between mRNA expression and 
protein levels are found in a few cases (Ideker et al., 2001; Siddiquee et al., 2004). When the 
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ratios of enzyme activity can be replaced by the ratios of CEF, the EMCs for the mutant are 
provided by equation (2.40) as follows: 
 
1
,
n
mut w
j j i
i
wt mut   

                 (2.42) 
Finally, when we get the EMCs of the mutant type, then the predicted flux distribution is 
provided by the following form as follows: 
mut mutv  P                                       (2.43) 
2.6 Integrated Biological Network Analysis 
 
The earlier cited and described methods are aim to incorporate heterogeneous 
biological data into metabolic network. Some of those which augment metabolic network 
with the gene expression, gene regulatory network or enzyme activity profile. The EM-based 
algorithms are potentially effective for integrating transcriptome or proteome data into 
metabolic network analyses and in exploring the mechanism of how phenotypic or metabolic 
flux distribution is changed with respect to environmental and genetic perturbations with a 
certain condition. In this section, we will present in more details about the recent effort of 
integrated biological network analysis aiming for more accurate prediction of the cellular 
phenotype for the given environment and growth conditions. 
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Figure 2.7: A flow chart of the GMF algorithm. 
2.6.1 Integrative Omics-Metabolic Analysis 
 
Integrative omics-metabolic analysis (IOMA) was proposed for the prediction of flux 
distribution from a metabolic network by integrating of quantitative proteomics and 
metabolomics data with a genome-scale metabolic models (Yizhak et al., 2010). IOMA was 
shown to successfully predict the metabolic state of human erythrocytes and E. coli under 
different gene knockouts (Yizhak et al., 2010). IOMA was displaying a significant 
improvement to compare with a less comprehensive method such as FBA, which depends on 
a definition of a cellular objective function or earlier described MOMA, which depends on 
data regarding the wild-type flux distribution. The general framework of IOMA formulated 
as a QP problem which minimizes the inconsistency between the flux predicted by the 
metabolic network model and the one obtained from the metabolomic and proteomic data 
using the Michaelis-Menten (MM) kinetics. 
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2.6.2 Integrative Metabolic Analysis Tool 
 
Integrative Metabolic Analysis Tool (iMAT) have been proposed for scientifically 
predicting the human tissue-specific metabolic behavior by integrating the tissue-specific 
gene and protein expression data with the genome-scale metabolic network under the 
assumed steady-state constraints (Shlomi et al., 2008). The iMAT was done by modifying 
Boolean mapping values of 1 and 0 to account for expression states, highly and lowly 
expressed genes, respectively, and replacing with ‘max’ and ‘min’ by the logical operators 
‘and’ and ‘or’ expressions, respectively. The expression data are given in two subsets HR  
and ,LR  which indicate the highly expressed (over- or under-expressed) and lowly expressed. 
The subset LR  used binary variable ,iy
 if the i-th reaction is truly lowly expressed in the 
problem. Similarly, HR  is used binary variable iy
  and ,iy if the i-th reaction is highly 
over-expressed and under-expressed, respectively. The framework of  iMAT was formulated 
to find a steady-state flux distribution by satisfying the stoichiometric and thermodynamic 
constraints of the following MILP problem as follows:  
 
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 
min, max,
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     
    
                        (2.44) 
This integration of  heterogeneous biological data is implemented in the iMAT tool as 
described elsewhere (Zur et al., 2010). 
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2.7 Network Redundancies and Inconsistencies 
 
The cellular life is a highly redundant complex system and the evolutionary maintenance 
of the redundancy remains unexplained (Wang and Zhang, 2009). Metabolic network may 
have redundant metabolites and reactions, whereby eliminating them from the original 
network may significantly simplify the analysis. In the constraint-based metabolic network 
analysis of the metabolic networks, most of the known reduction methods are analogous to 
the methods for the reduction of linear equality and inequality constraints (Luenberger, 2003; 
Gagneur and Klamt, 2004). The known reduction techniques for network redundancies and 
inconsistencies as follows: 
1. Metabolite conservation relations are a linear dependency related to the among rows 
of the stoichiometry matrix. The metabolic network can be simplified by removing 
the redundant metabolites having dependency relation in the network. It suffices to 
reduce the stoichiometry matrix S to a maximal linearly independent set of rows using 
simple linear algebra. 
2. Strictly detailed, balanced reactions those values are zero in any quasi-steady state the 
network. Which can be identified by solving a simple linear program of the 
stoichiometry matrix S. 
3. Uniquely produced (consumed) metabolite is a metabolite m which is produced 
(consumed) by a single reaction 0,tv and respectively consumed (produced) by i-th 
other reactions, namely 1 2, ,..., .t t tiv v v Metabolite m and 1i  reactions can be removed 
and substituted with i-th new reactions. 
4. Enzyme subset is defined as a subset of reactions at any steady state. If the enzyme 
subset has k reactions 1 2, ,..., ,t t tiv v v then 1i  of them can be eliminated from the 
network, as their later recovery is possible if a flux of the one remaining reaction is 
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known. The reactions of enzyme subsets are computed using the right null space 
matrix R of the stoichiometry matrix S. 
 
2.8 Conclusion 
 
The computational or mathematical models can be useful to identify the structure of a 
metabolic network that links the cellular phenotype to the corresponding genotype, although 
those networks are often large and complex. Constraint-based metabolic network analysis 
employs two approaches, optimization-based and pathway-based analysis, which are used for 
predicting the steady-state intracellular fluxes from the metabolic network by  integrating of 
the experimental data from genomics, transcriptomics, proteomics, metabolomics, and 
fluxomics, which are determined by high-throughput technologies. Pathway-based analysis is 
the most widely used and more advantageous than optimization-based analysis, because it 
generally employs without the specifying the cellular objective function. Comparison 
between some optimization-based and pathway-based metabolic network analysis and its 
applications are shown in table 2.1. Metabolic pathway analysis aims to discover and analyze 
meaningful routes involved in the metabolic networks, linking the cellular behavior with its 
inherent metabolic network structure. In this chapter, we describe details about the integration 
of the heterogeneous biological data into the metabolic network of the optimization-based 
analysis methods, e.g., FBA, MOMA, ROOM, FVA, with some genetically modified 
algorithms, e.g., OptKnock, RobustKnock, OptReg, OptGene, OptGene, OptForce and 
pathway-based analysis methods, e.g., MFA, EM, Expa, CEF, mCEF, ECF, GMF. Also,  we 
describe the integration of quantitative proteomics and metabolomics data, and tissue-specific 
gene and protein expression data with the genome-scale metabolic network by integrating 
biological network analysis. 
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Table 2.1: Comparison between some optimization-based and pathway-based metabolic 
network analysis and its applications based on (Jiang, 2006). 
 
√ = Applicable ,  = Not Applicable 
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Chapter 3  
 
Materials and Methods 
 
3.1 Introduction 
We develop the complementary elementary mode (cEM) analysis to efficiently analyze a 
large-scale metabolic network without enumerating the whole set of EMs/Expas. The cEM 
analysis provides a method, including the EM decomposition and maximum entropy principle 
(MEP), that can efficiently help to computations of complex metabolic systems (Badsha et 
al,., 2014). The general framework of  cEM analysis is shown in figure 3.1. 
 
Figure 3.1: The general framework of  cEM analysis. 
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3.2 Complementary Elementary Mode Algorithm 
 
The cEM analysis presents a new method to analyze complex metabolic networks, it 
combines by three steps: generated many flux distributions by flux balance analysis (FBA) as 
the input data necessary for the EM decomposition method, reduce the number of EM or 
decompose the EM (we called cEM) by the EM decomposition method, and flux prediction 
by maximum entropy principle (MEP). The algorithm for cEM analysis in a given steady-
state metabolic network is presented by a flow chart as shown in figure 3.2. The details of 
cEM method are as follows:   
 
Figure 3.2: A flow chart of cEM analysis. The gray square boxes are the data.The ovals are 
the algorithms. 
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3.2.1 Flux Balance Analysis 
 
First, we employ the flux balance analysis (FBA) to determine or generating many 
metabolic flux distributions that the EM decomposition method necessary as the input file 
(Figure 3.2). We maximize and minimize each flux distribution at the steady-state level for 
estimating multiple solutions of metabolic flux distributions, as the following linear 
programming (LP)  problem: 
1 2
for       i 1, 2, 3,  . . . ,  
Maximize ( , ,..., )
1000 1000
Subject to: 0                                            (3.1)
0 1000
for         i 1, 2, 3,  . . . ,  
Minimize
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i n
rev
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irrev
i
n
v v v
v
v
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

      

v
S v
v 1 2( , ,..., )
Subject to: 0
t
i nv v v
 S v
 
Where, v is the flux vector with a total number of reactions is n and S is the stoichiometric 
matrix. The aforementioned optimization, LP problem is performed using MATLAB 
(Mathworks Inc., Natick, MA).  At the most, the employed FBA method can estimate two 
sets of fluxes such that,  2× the flux number to be estimated.  
3.2.2 EM Decomposition of Metabolic Networks 
 
Second, we employ the EM decomposition method (Ip et al., 2011) to decompose the 
EMs, which determines the major EMs or linear combinations of EMs responsible for 
predicting the metabolic flux distributions, because computation of the full set of EMs in 
large-scale metabolic networks is still challenging and sometimes impossible due to its 
underlying combinatorial complexity. Since EM decomposition are not unique, thus the goal 
of this method is to assist in the biological interpretation with obtaining a valid 
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decomposition rather than any specific decomposition. The EM decomposition method does 
not pick up all EMs, but finds the decomposed pathways that can maintain the metabolic flux 
at the steady-state level. Those decomposed pathways are named cEMs. The space spanned 
by the cEMs is included in the space spanned by all the EMs, or cEMs are a subset of EMs.  
To obtain cEMs, the EM decomposition method would require many different flux 
distributions as input. Thus, FBA is used to estimate the entire flux distributions that the EM 
decomposition method requires as input. The EM decomposition method is an iterative 
method, first selects the reaction with non-zero flux from a given flux distribution (those are 
already estimated by FBA) and then applies the mixed integer linear programming (MILP) to 
find the cEMs that are contained by both the selected and given distributions. Then, it 
determines the contribution of the cEMs to the given flux distribution. Subtracting the 
contribution from the given flux distribution presents an updated flux distribution. At the next 
iteration step, the updated flux distribution is used as the input. This process is repeated until 
the updated flux distribution approaches to zero. This algorithm takes as input a flux 
distribution v in the feasible set of optimization problem in equation (3.1) with the FBA 
model (e.g., S, n, q) (Figure 3.2) and outputs set of cEMs {p(k)}, which generates v  as 
follows: 
 K
k
k 1
 ,k

 v p λ                                                                                                                               (3.2) 
where λk is the cEM coefficient, K is the number of cEMs, and q is the number of metabolites. 
Detail explanation of EM decomposition is described elsewhere (Ip et al., 2011). 
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3.2.3 Maximum Entropy Principle 
 
In the statement of the problem section, we privilege that many organisms still does 
not provide any specific biological objective function for estimating the coefficients of 
EMs/Expas/cEMs and EMs can be described by different scalar products or many possible 
vectors of each EM, but the predicted flux distributions must be independent of them. The 
maximum entropy principle (MEP) is convenient in cases where no biological objective 
function is available and does not depend on scalar products of each EM/Expa/cEM (Zhao 
and Kurata, 2009a and 2010; Badsha et al., 2013). MEP is derived from Shannon's 
information theory and is widely used in physics, chemistry, and Bioinformatics for gene 
expression (Lezon et al., 2006) and sequence analysis (Capra and Singh, 2007; Martin et al., 
2005). MEP can widely be implemented in metabolic network analysis for flux predictions 
(Badsha et al., 2014). 
Third, the MEP is used as an objective function to estimate the coefficients of 
EMs/Expas/cEMs (Figure 3.2). Usually, the metabolic flux distribution at steady-state level 
can be decomposed onto EMs/Expas/cEMs as follows:                    
d d  v P                                                                                                                (3.3) 
Pd is the sub-matrix of EM/Expa/cEM matrix in which the determined fluxes are represented 
by the rows and the EMs/Expas/cEMs by the columns. vd is the flux vector with the 
determined reactions and λ is the coefficients of EMs/Expas/cEMs. Shannon's Entropy  is 
denoted by I and defined as follows: 
1
log   ,
ne
j j
j
I  

                                                                    (3.4) 
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where, j is the probability of EM/Expa/cEM and  
1
1;
ne
j
j


  ne is the the number of 
EMs/Expas/cEMs. The probability of each EM/Expa/cEM is presented as follows: 
substrate uptak,
1substrate uptake
1 1   ,
ne
j j j j
jv
  

      P                                                  (3.5) 
where, substrate uptakev is the substrate uptake of a flux, substrate uptake, jP is the element of the jth 
EM/Expa/cEM. Assuming that the contribution of the internal loops ( substrate uptake, 0j P ) is 
neglected based on loop law thermodynamic constraints (price et al., 2006). The internal loop 
has two reactions, South and frd  in the employed metabolic network model of E. coli (See 
reaction 29 and 30 in the appendix A). The probability of each EM/Expa/cEM, j  is provided 
by solving the following MEP optimization problem as follows: 
 
1
1
Maximize     - log                                                                                     3.6
subject to      1                                                           
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j j
j
ne
j
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 
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                                3.7
( 1,2,..., )  ,                                                                             3.8
ne
j r j r
j
v r nd

  x
where, vr is the r-th determined flux and nd is the number of the determined fluxes. New 
matrix xr,j, converted from EM/Expa/cEM matrix Pd. There are mainly three steps to apply 
the MEP objective function for the flux prediction as given below: 
Step-1: Normalization of EM/Expa/cEM matrix is given by following form as follows: 
, ,
,,
,
          ( 0)
0              ( 0) ,
substrate uptake
r j substrate uptake j
substrate uptake jr j
substrate uptake j
v
p if p
p
if p
   
x                                       (3.9)                         
where, jrp ,  is the element of the r-th determined flux and j-th EM/Expa/cEM.  
Step-2: Convert  the nonlinear program problem to make a nonlinear equation as follows: 
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The nonlinear equation (3.7) for ψ could be solved by mmfsolve or fsolve in Matlab (Hasbun, 
2008). 
Step-3: The probabilities of EM/Expa/cEM, j  and  coefficient of EM/Expa/cEM, j  are 
calculated by the following two equations as follows: 
,
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v
if p
p
if p

   
                                                  (3.12) 
Finally, the metabolic flux distribution of the target model is predicted as follows: 
target target v P                  (3.13) 
Detail explanation of MEP is described elsewhere (Zhao and Kurata, 2009a, 2010). 
3.4 Quantitative Contributions 
 
The quantitative contribution to input flux is the measure of how much each cEM/EM is 
responsible for the input flux, because all of the cEM/EM go through the input flux (Badsha 
et al., 2014). After applying the MEP step, we calculate the quantitative contribution of each 
cEM/EM to input flux. The quantitative contribution to input flux is defined as: 
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 Quantitative contributions , ,j numuptake j P                                                     (3.14) 
where, λ is the coefficient vector of cEMs/EMs, j is the interest index of cEMs/EMs, and 
numuptake is the row index that corresponds to the uptake or input flux. 
We could be checking the critical cEMs to guarantee the quality of the metabolic flux 
prediction and to validate the algorithm. The critical number of cEMs is the minimum 
number that can accurately predict the flux distributions, at which the prediction difference 
(Equation 3.16) almost converges with respect to the number of cEMs. We rank the total 
unique cEMs for finding a critical number of cEMs according to their quantitative 
contributions to input flux.   
3.5 Prediction Accuracy 
 
The prediction error in the metabolic flux distributions by EM/Expa/cEM analyses is 
defined as follows: 
 2,predection ,exp
1
1Predection error v ,
nd
r r
r
v
nd 
                                              (3.15) 
where, ,predectionvr  is the predicted flux for the r-th reaction, ,exprv  is the experimental data of 
the r-th reaction, and nd is the number of the determined fluxes. The prediction difference in 
the metabolic flux distributions between by the cEM and EM/Expa analyses are defined as 
follows: 
 2,cEM ,EM/Expa
1
1Predection difference v ,  
nu
g g
g
v
nu 
                                  (3.16) 
where, ,cEMvg  and ,EM/Expagv are the predicted fluxes for the g-th reaction by cEM and 
EM/Expa analyses, respectively, and nu is the number of the unmeasured fluxes. 
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3.6 Implementation 
 
The EMs were calculated by the CellNetAnalyzer (CNA), which is a package for 
MATLAB and provides a comprehensive and user-friendly environment for structural and 
functional analysis of biochemical networks and used for calculation of EMs and Expas 
(Klamt et al., 2007) and elementary flux mode tool (efmtool) (Terzer and Stelling, 2007), 
which is implemented in Java and has been integrated into MATLAB. The Expas were 
calculated by the CNA with an optional setting (Klamt et al., 2007). The EM decomposition 
method was implemented using MATLAB with Gurobi 4.0. The Gurobi optimizer is 
necessary for the EM decomposition method. The optimization of the coefficients of 
EMs/Expas/cEMs and the prediction of the flux distributions were performed in MATLAB 
R2014a. The employed computer is the Dell- Windows 7 Professional (Intel-R Core-TM i7-
3770; CPU 3.40 GHz; Memory-RAM, 8.00 GB). 
3.7 Metabolic Network Models 
 
To investigate the applicability of cEM analysis, compare with EM analysis, we used two 
medium-scale metabolic networks of E. coli (Hua et al., 2006) and one genome-scale 
metabolic network of head and neck cancer cells (Agren et al., 2012). Details in the metabolic 
network models are shown in Table 3.1 (The reactions and metabolites of E. coli models are 
shown in Appendix A). The model-I has 140 metabolites and 156 reactions, including 
reaction 1–5, 7–104, and 107–159 (Figure B.1); model-II has 140 metabolites and 157 
reactions, including reaction 1–104 and 107–159 (Figure B.2). The experimental flux 
distributions for E. coli were determined by 13C tracer experiments (Hua et al., 2006). The 
model-I indicates the E. coli pta-adhE-pfkA-glk gene knockout mutant undergoing adaptive 
evolution for 30 and 60 days under anaerobic condition. The model-II indicates the E. coli 
pta-pfkA gene knockout mutants undergoing adaptive evolution for 30 and 60 days. GMF is 
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applied to predict the metabolic flux distributions of the genetic mutants of model-I and 
model-II, where pgi and ppc genes are over-expressed (The relative enzyme activity ratio of a 
mutant versus wild type is more than 1) and, aceA and zwf genes are under-expressed (The 
relative enzyme activity ratio of a mutant versus wild type is less than 1). Model-III indicates 
the genome-scale metabolic network of head and neck cancer cells with 4487 metabolites and 
2931 reactions. No experimental flux data are available for model-III. 
Table 3.1: Details for two metabolic network models of E. coli and a genome-scale 
metabolic network model of head and neck cancer cells (Badsha et al., 2014). 
Model I II III 
O2 Anaerobic Anaerobic  
Substrates Glucose Glucose  
Products  Acetate, ethanol, succinate, 
glycerol, formate, lactate, CO2
Acetate, ethanol, succinate, 
glycerol, formate, lactate, CO2 
 
# Reactions 156 157 2931 
# Metabolites 140 140 4487 
 
3.8 Conclusion 
A metabolic flux distribution is the consequence of complex regulations at the enzyme 
level. A regulatory network is built from the interaction of various levels, such as gene 
expression, protein-protein interaction and intracellular metabolic reactions. In this chapter, 
we presented a fast and efficient algorithm, complementary elementary modes (cEMs) 
analysis to efficiently analyze a large-scale metabolic network. The cEM analysis consists of 
the FBA, EM decomposition method, and MEP. To rationally design of  metabolic networks, 
the cEMs are very effective in integration of gene expression data into large-scale models by 
GMF. 
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Chapter 4 
 
Results and Discussions 
 
 
4.1 Introduction 
 
We consider both artificial and real metabolic network analyses for comparison between 
the performance and applicability of the cEM and existing EM/Expa algorithms.  
 
4.2 Simulation Study 
 
To investigate the performance of the cEM analysis in a comparison of the existing 
EM/Expa analysis, we consider a synthetic metabolic network as shown in figure 4.1. 
4.2.1 Artificial Metabolic Network 
 
To explain the procedure of the cEM analysis, we applied to the following plain 
artificial metabolic network model (figure 4.1). Where X1, X2 and X3 (cycles) are the 
internal metabolites that need to fulfill a steady-state, while X1ex, X2ex and X3ex (squares) are 
the external metabolites that need not be balanced in this scheme. The input flux of v1 is fixed 
to 100. We have to predict the unknown fluxes 2 3 4 5 6 7( , , , , , ).v v v v v v  
 
 
 -74- 
 
  
Figure 4.1: Synthetic metabolic network 
The above synthetic metabolic model can be represented by a stoichiometric matrix, S. For 
the given model, the metabolites are represented by the rows of S and the columns of S 
correspond to the reactions in a network. The coefficient of stoichiometric matrix S,  we use 
positive (+) sign for a metabolite is formed (produced) by the reaction and negative (-) sign 
for a metabolite is consumed by the reaction. Then, we can express S  for the synthetic 
metabolic network as follows: 
1 2 3 4 5 6 7              v    v     v    v       v     v   v
X1 1  -1   -1  0    0    0  0
X2 0 1   0 1 -1    0 -1
X3 0 0 1 -1 0 -1 1
      
S
                                                                            (4.1) 
At the steady-state level, the equations are given by: 
0v S                                                                                                                     (4.2)                          
System boundary 
100
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EM/Expa analysis 
We get 5 EM/Expa by applying the EM/Expa analysis of the synthetic metabolic 
network. We found that the same number of EM and Expa, because there is no reversible 
reaction are involved in the synthetic metabolic network model that shown in figure 4.1. The 
EM/Expa analysis results are illustrated in the figure 4.2. 
 
 
Figure 4.2: EM/Expa analysis of synthetic metabolic network. 
 
Scalar product of EM analysis 
The EM can be described by many possible vector or scalar products of each EM. To 
describe the scalar product problem of EM analysis, we consider the synthetic metabolic 
network as shown in figure 4.1. The following equations 4.3, 4.4 and 4.5 are the possible 
vector or scalar products of each EM. 
Metabolic network
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We can write the above equation 4.3 as the following from as follows: 
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Compare with existing EM/Expa analysis, we apply the cEM analysis, which consists of 
three steps as follows (details are described in the materials and method section): 
 
Step-1: Flux balance analysis (FBA) 
        First, we employ the FBA method to determine the possible metabolic flux distributions, 
which are necessary for the EM decomposition method. In the FBA, multiple solutions of 
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metabolic flux distributions are calculated by maximizing and minimizing each flux in a 
given steady-state as follows: 

2 3 4 5 6 7
1
Maximize ( , , , , , )
for       i 2, 3, 4,  5, 6, 7    and 100
Subject to: 0    1 -8  1000   (all reactions are irreversible)              (4.6)                         
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The upper bound (ub) for all reactions is set to 1000 and the lower bound (lb) is set to 1e-8 
(Since all reactions are irreversible). Input flux 1v is fixed to 100 
1 1 1(for v , ub 100 and lb 100)   and the other 12 sets of metabolic flux distributions are 
estimated by maximizing and minimizing each flux (solve equation (4.6)) as the following 
table 4.1. 
Table 4.1: 12 sets of flux distributions are estimated by solving equation 4.6. 
V2 V3 V4 V5 V6 V7 
Max Min Max Min Max Min Max Min Max Min Max Min
100 
100 
0 
0 
66.67 
33.33 
33.33 
100 
0 
100 
33.33 
33.33 
66.67 
0 
100 
0 
100 
33.33 
33.33 
66.67 
0 
100 
100 
0 
0 
66.67 
33.33 
33.33 
100 
0 
100 
1000 
100 
0 
900
100 
50 
50 
0 
50 
50 
0
100 
66.67 
33.33 
33.33 
100 
0 
0
100 
33.33 
66.67 
0 
0 
100 
33.33
100 
33.33 
66.67 
0 
0 
100 
33.33
100 
66.67 
33.33 
33.33 
100 
0 
0 
100 
100 
0 
900 
0 
100 
1000 
100 
50 
50 
0 
50 
50 
0
 
Then, we have to select the unique or independent flux. Because, if we use the same flux for 
the input file of EM decomposition then we get the same cEM. Therefore, we take seven 
independent or unique sets from the 12 sets, as shown by the following table as follows: 
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Table 4.2: Seven independent / unique sets from table 4.1. 
1 2 3 4 5 6 7 
100 
100 
0 
0 
66.67 
33.33 
33.33 
100 
0 
100 
33.33 
33.33 
66.67 
0 
100 
0 
100 
1000 
100 
0 
900 
100 
50 
50 
0 
50 
50 
0 
100 
66.67 
33.33 
33.33 
100 
0 
0 
100 
33.33 
66.67 
0 
0 
100 
33.33 
100 
100 
0 
900 
0 
100 
1000 
 
 
Step-2: Elementary mode (EM) decomposition 
           Second, we apply the EM decomposition technique, which generates the major EMs or 
linear combination of EMs (cEMs), which are the responsible for the flux distributions. The 
EM decomposition method uses mixed integer linear programming (MILP) to find the cEMs 
that satisfy the steady-state condition for 7 unique sets of flux distributions. We obtain 5 
independent or unique cEMs from 7 sets of flux distribution as follows: 
7 5
cEM1 cEM2 cEM3 cEM4 cEM5
0.5774 0.5774 0.5 0.5 0
0.5774 0 0 0.5 0
0 0.5774 0.5 0 0
cEM ( )
0 0 0.5 0 0.7071
0.5774 0 0.5 0 0
0 0.5774 0 0.5 0
0 0 0 0.5 0.7071 
              
P               (4.7) 
 
Step-3: Maximum entropy principle (MEP) 
Third, we use the MEP as an objective function to estimate the 5 coefficients of cEMs, 
to avoiding the scalar product problem of EM. By removing a closed pathway, the  following 
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4 cEMs were found enough to estimate the flux distributions, at which the predicted 
difference is zero. The 4 cEM by the cEM analysis as follows:  
7 4
cEM1 cEM2 cEM3 cEM4
0.5774 0.5774 0.5 0.5
0.5774 0 0 0.5
0 0.5774 0.5 0
cEM= 
0 0 0.5 0
0.5774 0 0.5 0
0 0.5774 0 0.5
0 0 0 0.5 
             
                                                                  (4.8)                        
The metabolic flux distributions predicted by the cEM analysis are given as follows: 
 
 
 
         
 
 
 
4.3 Real Metabolic Network 
4.3.1 Flux Predictions 
 
To demonstrate the feasibility of cEM analysis compared with ordinary EM analysis, 
we calculated the flux distribution of two metabolic networks of E. coli (Badsha et al., 2014). 
In model-I, the cEM analysis generated 202 unique cEMs, while the EM analysis generated 
122,126 EMs by using the CNA and efmtool. In model-II, cEM analysis generated 295 
unique cEMs and EM analysis did 321,416 EMs. 
 
 
Flux distributions 
100 
50 
50 
25 
50 
50 
25 
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4.3.1.1 Model-I 
In model-I, the flux distributions were estimated by both cEM and EM analyses, as 
shown in figure 4.3. The predicted flux distributions were compared with 26 experimental 
fluxes (Hua et al., 2006) as shown in figure 4.3(A, B). Figure 4.3(A) and 4.3(B) shows the 
flux prediction for 30-day-cultured cells and 60-day-cultured cells, respectively. The 130 
unmeasured fluxes predicted by the cEMs were compared with those by the EMs generated 
by CNA in figure 4.3(C, D). Figure 4.3(C) and 4.3(D) shows the 130 unmeasured predicted 
flux for 30-day-cultured cells and 60-day-cultured cells, respectively. The prediction errors as 
defined by equation (3.15), are calculated by cEM and EM analyses for 30 and 60-day-
cultured cells as shown in figure 4.3(E). From these figures 4.3(A-B), we have seen that, the 
predicted flux distribution by the cEMs was very consistent with the experimental data and 
also consistent with the predicted flux distribution by the EMs. Moreover, figure 4.3(B-C) to 
confirm that the unmeasured predicted fluxes was very closely related to the cEM and EM 
analyses.     Here, 29 critical cEMs were selected out of 202, as shown in figure 4.3(F). To 
find a critical number of cEMs, we ranked the total 202 cEMs according to their quantitative 
contributions to input flux and estimated the prediction differences by equation (3.16). The 
29 critical cEMs, which are only a 2.4×10-4 portion of the total EMs, were found enough to 
estimate the flux distributions, at which the prediction difference almost converged as shown 
in figure 4.3(F).   
4.3.1.2 Model-II 
In model-II, the flux distributions were estimated by both cEM and EM analyses by 
CNA, as shown in figure 4.4. In figure 4.4(A, B) the predicted flux distributions were 
compared with 26 experimental fluxes (Hua et al., 2006). The predicted fluxes for 30-day-
cultured cells and 60-day-cultured cells are shown in figures 4.4(A) and 4.4(B), respectively. 
In figure 4.4(C, D), the 131 unmeasured fluxes predicted by the cEMs were compared with 
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those by the EMs. The predicted 131 unmeasured fluxes for 30-day-cultured cells and 60-
day-cultured cells, are shown in figure 4.4(C) and 4.4(D),  respectively. The prediction errors 
for cEM and EM analyses are shown in figure 4.4(E). In analysis of figures 4.4(A-B), we 
have seen that the predicted flux distributions by the cEMs were consistent with the 
experimental data and also consistent with the predicted flux distribution by the EMs. The 
predicted unmeasured fluxes also very consistent by the cEM and EM analyses. In the same 
manner as figure 4.3(F), we ranked the total 295 cEMs due to their quantitative contributions 
to input flux and calculated the prediction difference as shown in figure 4.4(F).  The 35 
critical cEMs, which are only a 1.1×10-4 portion of the total EMs, were found enough to 
estimate the flux distributions, at which the prediction difference almost converged as shown 
in figure 4.4(F). 
 
In both model-I and model-II, the prediction errors by the cEMs were comparable to 
those by the EMs, presenting that cEMs are effective in prediction of the flux distribution and 
that a very small portion of the total EMs are enough to predict flux distributions, at which 
the prediction difference almost converged. On the other hand, the prediction difference 
between cEM and EM analyses did not become zero, as shown in figure 4.3(F) and figure 
4.4(F), suggesting that many EMs with a small value of EMCs can a little affect the flux 
distributions. The difference would be also caused by the fact that a set of the critical cEMs 
are different from that of the EMs, as shown in Section 4.3.3. 
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Figure 4.3: Flux distributions predicted by cEM and EM analyses for model-I of E. coli 
mutants. (A and B) The predicted flux distributions are compared with 26 experimental 
fluxes for 30-day-cultured cells (A) and 60-day-cultured cells (B). (C and D) The predicted 
flux distribution by the cEMs is compared with that by the EMs for 30-day-cultured cells (C) 
and 60-day-cultured cells (D), where 130 unmeasured fluxes are estimated. (E) The 
prediction errors are calculated by cEM (gray) and EM (black) analyses for 30 and 60-day-
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cultured cells (A and B). (F) The prediction difference is plotted with respect of the number 
of cEMs. 
 
Figure 4.4: Flux distributions predicted by cEM and EM analyses for model-II of E. coli 
mutants. (A and B) The predicted flux distributions are compared with 26 experimental 
fluxes for 30-days-cultured cells (A) and 60-day-cultured cells (B). (C and D) The predicted 
flux distribution by the cEMs is compared with that by the EMs for 30-day-cultured cells (C) 
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and 60-day-cultured cells (D), where 131 unmeasured fluxes are estimated. (E) The 
prediction errors are calculated by cEM (gray) and EM (black) analyses for 30-and 60-day-
cultured cells (A and B). (F) The prediction difference is plotted with respect of the number 
of cEMs. 
4.3.2 Statistical Analysis of Prediction Accuracy 
 
A measure of prediction accuracy by statistical analysis is an important process for 
comparing the two systems. To show a correlation between the predicted and experimental 
fluxes for model-I and model-II, we performed a statistical analysis using a linear regression 
model (Badsha et al., 2014). Table 4.3 shows the Pearson’s correlation coefficient (r) 
(Pearson, 1895), the coefficients of determination (R2) (Steel, and Torrie, 1960) between the 
experimental and predicted fluxes, and P values (Goodman, 1999) for cEM and EM analyses. 
The P values are used for testing the hypothesis that the predicted and experimental flux 
distributions are uncorrelated. The correlation coefficients range between 0.9634 and 0.9989, 
the coefficients of determinations range from 0.9281 to 0.9978, and the P values from 
1.9×10-33 to 3.4×10-15. These statistical analyses demonstrate that the correlation coefficient 
and coefficients of determination are remarkably high and the P values are significantly small 
(i.e., reject the hypothesis at the 5% level of significance), presenting a statistical high 
consistency between the experimental and predicted fluxes by the cEM and EM analyses. 
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Table 4.3: The Pearson’s correlation coefficient (r), the coefficients of determination (R2) 
between the experimental and predicted fluxes and P values by the cEM and EM analyses. 
 
Model 
 
Condition 
 
Method 
Pearson's 
Correlation (r) 
Coefficients of 
determination (R2)  
 
P value 
 
 
Model-I 
 
Wild type 
EM 0.9980 0.9960 2.4×10-30 
cEM 0.9982 0.9964 7.4×10-31 
 
Mutant type EM 0.9973 0.9947 7.9×10
-29 
cEM 0.9975 0.9950 3.5×10-30 
 
 
Model-II 
 
Wild type 
EM 0.9639 0.9291 2.6×10-15 
cEM 0.9634 0.9281 3.4×10-15 
 
Mutant type EM 0.9989 0.9978 1.9×10
-33 
cEM 0.9789 0.9878 1.7×10-20 
 
4.3.3 Quantitative Contributions of cEMs and EMs 
 
To make clear the difference between cEM and EM analyses, we characterized the 
critical 29 and 35 cEMs and their quantitative contributions to the input flux (Badsha et al., 
2014). We estimated the quantitative contribution by calculating how much each cEM/EM is 
responsible for the input flux (Equation 3.14), because all the cEMs and EMs go through the 
input flux. The employed cEMs and EMs and their quantitative contributions are summarized 
using Venn-diagrams for model-I and model-II, as shown in figure 4.5. 
4.3.3.1 Model-I 
 
To calculate the quantitative contribution to input flux for model-I, the input flux 
(glucose uptake) was set to 1. The number of cEMs was set to 29 as the same cEMs as used 
for flux prediction, while that of EMs was set to 122,126. We sorted the cEMs/EMs in the 
descending order of their contributions, respectively. Top four cEMs and EMs were the same, 
while their quantitative contributions to input flux were a little bit different between both the 
cEMs and EMs analyses, as shown in figure 4.6(A). The pathway length and quantitative 
contributions to input flux with respect to the 4 consistent cEMs/EMs are listed in table 4.4. 
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The maximum contribution of the cEM analysis with a pathway length of 14 was 
approximately 0.1680, whereas that of the EM analysis with a pathway length of 15 was 
0.2002.   
 
 
Figure 4.5: Venn-diagram (A) Model-I and (B) Model-II. The employed cEMs and EMs and 
their quantitative contributions to input flux are illustrated. 
The maximum contribution of the cEM analysis with a pathway length of 14 was 
approximately 0.1680, whereas that of the EM analysis with a pathway length of 15 was 
0.2002. In general, the pathway length of biomass formation is long, because it includes 
many reactions of amino acids, DNA, and RNA syntheses. The pathway length of lactate 
production is short, as they belong to glycolysis and pyruvate metabolism. The metabolic 
pathways of the 4 consistent cEMs/EMs are shown in figure B.2 (Appendix B). The 4 
cEMs/EMs were not related to biomass formation, but were related to the formation of 
lactate; one of them was coupled with ATP drain. Thus, the pathway lengths for the 
consistent cEMs/EMs were short. The cEM with the maximum contribution, which is related 
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to ATP drain, showed 16.80%; its corresponding EM analysis did 12.14%. These 4 consistent 
cEMs showed total 61.87% contribution to input flux; the corresponding EMs did 56.45%.  
 
Table 4.4: The four consistent EMs or cEMs. Pathway length and quantitative contributions 
to input flux by the cEM and EM analyses for model-I. The metabolic pathway maps of the 
four EMs or cEMs are shown in figure B.2. 
Method Number Pathway length Quantitative contributions 
EM 2,     4,     5,    3 14,14,15,14 0.1214, 0.1214, 0.2002, 0.1214 
cEM 42,  43,   44,  49 14,14,15,14 0.1667, 0.1667, 0.1174, 0.1680 
 
4.3.3.2 Model-II 
 
In model II, the 35 critical cEMs were used, while the number of EMs was 321,416. 
We sorted the cEMs and EMs in the descending order of their contribution, respectively. As 
shown in figure 4.6(B), the top twelve cEM and EMs were the same. The 12 consistent cEMs 
and EMs and their quantitative contributions to the input flux are listed in table 4.5. The 
maximum contribution of the cEM with a pathway length of 14 is 0.1070; that of the EM is 
0.0804. The metabolic pathways of the 12 consistent cEMs / EMs are shown in figure B.3 
(Appendix B). The 12 cEMs / EMs are not related to biomass formation, which are related to 
the formation of ethanol and lactate; some of them are coupled with ATP drain. The 12 
consistent cEMs showed total 67.16% contribution, whereas the 12 EMs did 48.08%.  
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Table 4.5: The 12 consistent EMs or cEMs. Pathway length and quantitative contributions by 
the cEM and EM analyses for model-II. The metabolic pathway maps of the 12 EMs or cEMs 
are shown in figure B.3. 
Method Number Pathway length Quantitative contributions 
 
EM 3, 4, 6, 7, 8, 11, 12, 
14, 26940, 26943, 
26945, 26946 
14, 14, 14, 14, 
14, 17, 17, 17, 
15,  16,  16,  16 
0.0804, 0.0804, 0.0804, 0.0804, 
0.0804, 0.0111, 0.0111, 0.0111, 
0.0114,   0.0114,    0.0114,   0.0114
 
cEM 
59,     57,   108, 102, 
101, 164, 162, 166, 
121,  77,   117,   118 
14, 14, 14, 14, 
14, 17, 17, 17, 
15,  16,  16,  16 
0.1070, 0.1062, 0.1069, 0.1062, 
0.1062, 0.0288, 0.0288, 0.0286, 
0.0132,   0.0132,    0.0132,   0.0132
  
The quantitative contribution of non-consistent cEMs was relatively large in both the models, 
while they did not deteriorate the prediction accuracy of the flux distributions (Figures 4.3A-
4.3E, 4.4A-4.4E).  The prediction difference between cEM and EM analyses (Figures 4.3F, 
4.4F) would be caused by the fact that a set of the critical cEMs are different from that of the 
EMs. 
4.3.4 GMF-Predicted Flux Distribution 
 
To further demonstrate the feasibility of cEMs, we applied the cEMs and EM to 
GMF-predicted flux distributions of the genetically modified model-I and model-II (Badsha 
et al., 2014).   
4.3.4.1 Model-I 
In the genetically modified model-I, the flux distribution were estimated with both 
cEM analysis and EM analysis by CNA, as shown in figure 4.7. In figure 4.7(A, B) the flux 
distributions predicted by cEM and EM analyses were compared with 26 experimental fluxes 
(Hua et al., 2006). The GMF-predicted flux distributions by cEM and EM analyses for 30-
day-cultured cells and 60-day-cultured cells, are shown in figure 4.7(A) and 4.7(B), 
respectively. In figure 4.7(C, D) the 130 unmeasured flux distributions predicted by the 29 
critical cEMs were compared with those by the EMs. The unmeasured flux distributions for 
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30-day-cultured cells and 60-day-cultured cells, are shown in figure 4.7(C) and 4.7(D), 
respectively. The prediction errors as defined in equation (3.7) between the GMF-estimated 
fluxes by cEM and EM analyses are shown in figure 4.7(E). In figure 4.7F, to find the critical 
number of cEMs, we sorted the total 202 unique cEMs in the descending order of their 
quantitative contributions to input flux and calculated the prediction differences between by 
cEM and EM analyses. The 29 critical cEMs were found enough to estimate the flux 
distributions for the genetically modified model-I, which were the same EMs as determined 
by figure 4.3F.  
4.3.4.2 Model-II 
In the genetically modified model-II, the flux distributions by both cEM and EM 
analyses are shown in figure 4.8. The 26 predicted fluxes were compared with the 
experimental flux distributions (Hua et al., 2006), as shown in figure 4.8(A, B). The GMF-
predicted flux distributions by cEM and EM analyses for 30-day-cultured cells and 60-day-
cultured cells, are shown in figure 4.8(A) and 4.8(B), respectively. In figure 4.8(C, D), the 
131 unmeasured flux distribution predicted by the cEMs were compared with those by the 
EMs. The 131 unmeasured flux distributions for 30-day-cultured cells and 60-day-cultured 
cells, are shown in figure 4.8(C) and 4.8(D), respectively. Figure 4.8(E) shows the prediction 
errors by cEM and EM analyses. In figure 4.8F, to find the critical number of cEMs, we 
sorted the total 295 unique cEMs in the descending order of their quantitative contributions to 
input flux and calculated the prediction differences between by cEM and EM analyses. The 
35 critical cEMs were found enough to estimate the flux distributions for the genetically 
modified model-I, which were the same EMs as determined by figure 4.4F.  
 
 -90- 
 
 
Figure 4.6: The consistent EMs/cEMs and their quantitative contributions to input flux. (A) 
Model-I and (B) Model-II. The value top of the bar diagram within the bracket indicates the 
pathway length. 
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Figure 4.7: Flux distributions predicted by GMF with the cEMs/EMs for the genetically 
modified model-I. (A and B) The GMF-predicted flux distributions are compared with 26 
experimental fluxes for 30-days-cultured cells (A) and 60-day-cultured cells (B). (C and D) 
The GMF-predicted flux distribution by the cEMs is compared with that by the EMs for 30-
day-cultured cells (C) and 60-day-cultured cells (D), where 130 unmeasured fluxes are 
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estimated. (E) The prediction errors are calculated by cEM (gray) and EM (black) analyses 
for 30- and 60-day-cultured cells (A and B). (F) The prediction difference is plotted with 
respect of the number of cEMs. 
 
Figure 4.8: Flux distributions predicted by GMF with the cEMs/EMs for the genetically 
modified model-II. (A and B) The GMF-predicted flux distributions are compared with 26 
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experimental fluxes for 30-day-cultured cells (A) and 60-day-cultured cells (B). (C and D) 
The GMF-predicted flux distribution by the cEMs is compared with that by the EMs for 30-
day-cultured cells (C) and 60-day-cultured cells (D), where 131 unmeasured fluxes are 
estimated. (E) The prediction errors are calculated by cEM (gray) and EM (black) analyses 
for 30- and 60-day-cultured cells (A and B). (F) The prediction difference is plotted with 
respect of the number of cEMs. 
4.3.5 Statistical Analysis of GMF-Prediction Accuracy 
The GMF-predicted flux distributions by cEM analysis are rather consistent with 
those by EM analysis. Some differences may be caused by the fact that the quantitative 
contributions of the critical cEMs are not the same as those of the EMs (Figures 4.6, 4.7 and 
4.8). To statistically characterize their consistency, the Pearson’s correlation coefficient (r), 
the coefficients of determination (R2) between the experimental and GMF-predicted flux 
distributions, and the P values by cEM and EM analyses are shown in table 4.6. The 
correlation coefficients range between 0.8723 and 0.9817, the coefficients of determinations 
range from 0.7610 to 0.9637, and the P values from 2.3×10-22 to 6.3×10-11. The correlation 
coefficient and coefficients of determination were remarkably high and the P values were 
significantly small (reject the hypothesis at the 5% level of significance). These results 
provided statistically significant correlation between the experimental fluxes and the GMF-
predicted ones by cEM and EM analyses. 
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Table 4.6:  The Pearson’s correlation coefficient (r), the coefficients of determination (R2) 
between the experimental and GMF-predicted fluxes and P values by the cEM and EM 
analyses. 
 
Model Adaptive evolution 
 
Method Pearson's 
Correlation (r) 
Coefficients of 
determination (R2)  
 
P value 
 
 
Model-I 
 
30 days EM 0.9496 0.9017 3.5×10
-16 
cEM 0.9380 0.8798 6.5×10-16 
 
60 days EM 0.9519 0.9061 2.5×10
-17 
cEM 0.9492 0.9010 4.9×10-17 
 
 
Model-II 
 
30 days 
EM 0.8723 0.7610 6.3×10-11 
cEM 0.9747 0.9500 1.1×10-20 
 
60 days 
EM 0.9817 0.9637 2.3×10-22 
cEM 0.9684 0.9378 1.6×10-19 
 
4.3.6 Comparison with Existing Methods 
We have made a clear example of the advantages of the cEM analysis compared to 
the existing EM/Expa analysis by calculation speed and accuracy. The speed and accuracy of 
cEM and EM/Expa analyses for the metabolic models are shown in table 4.7. The EM/Expa 
analyses consist of two steps: EM/Expa extraction by CNA and emftool, and flux prediction 
by MEP. On the other hand, the cEM analysis consists of three steps: FBA, EM 
decomposition for cEM extraction, and flux prediction by MEP.  The calculation speed of 
cEM analysis was 35-fold and 168-fold higher than the EM analysis by CNA, 4-fold and 6-
fold higher than Expa analysis, and 22-fold and 30-fold higher than the efmtool for model-I 
and model-II, respectively, whereas they did hardly deteriorated the prediction accuracy 
(Badsha et al., 2014). Both the processes of EM extraction (or FBA+EM decomposition) and 
MEP-based flux prediction were remarkably accelerated.  
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4.3.7 Critical Numbers of cEMs 
 
It is important to determine the critical cEMs critically responsible for flux prediction 
in order to guarantee the quality of the flux prediction. As shown in figures 4.3F, 4.4F, 4.5F, 
4.6F, a small number of cEMs was enough for the accurate prediction. We can check the 
critical cEMs to guarantee the quality of the flux prediction and to validate the algorithm. 
Consequently speaking, users can use all cEMs without any problems. At the critical number 
of cEMs, the prediction difference between cEM and EM analyses turned to a very gradual 
decrease or to be saturated with respect to the number of cEMs. Note that the critical number 
is less than 2×(the flux number to be estimated by FBA). If a large number of critical cEMs 
are required, we recommend a random sampling method, Constraint-based Reconstruction 
and Analysis (COBRA) (Becker et al., 2007) that can produce more flux distributions than 
the employed FBA. 
4.3.8 Application to a Large-scale/Genome-scale Metabolic Network 
 
To demonstrate the feasibility of cEM analysis and its applicability to large-scale or 
genome-scale metabolic models, we applied it to model-III (Agren et al., 2012). The 
EM/Expa analyses by CNA and efmtool were unable to find any EMs/Expas due to of 
calculation complexity or memory limitations. By contrast, use of cEM analysis generated 
804 cEMs using 2,249 flux distributions and estimated the flux distribution by MEP, as 
shown in table 4.7. The cEM analysis is found to be applicable to a genome-scale network. 
Note that no prediction error is calculated, because there is no experimental flux data (Badsha 
et al., 2014). 
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Table 4.7: Calculation speed and accuracy for the prediction of flux distributions by the cEM 
and EM/Expa analyses.  
Model Method # EM Total running time(s) Prediction error 
 
 
 
 
Model-I 
 
EM CNA 122126 600+780.871=1380.871
a 0.0233 
efmtool 122126 95+790.628=885.628a 0.0255 
Expa 1215 65+85.405=150.405a 0.0294 
cEM 202 7.94+30+1.561=39.501b 0.0268 
 
 
 
 
 
Model-II 
 
EM CNA 321416 6000+1000.568=7000.568
a 0.0813 
efmtool 321416 180+1070.326=1250.326a 0.0737 
Expa 3045 89+163.965=252.965a 0.0836 
cEM 295 8.08+32+1.605=41.685b 0.0975 
 
 
Model-III 
 
EM 
CNA * * * 
efmtool * * * 
Expa * * * 
 
cEM 
 
804 3517.2+7871.5+ 31.80 =11420.5b No experimental 
data 
a The EM/Expa analyses consist of two steps: EM/Expa extraction and flux prediction by 
MEP. b The cEM analysis consists of three steps: FBA, EM decomposition, and flux 
prediction by MEP. * Not applicable due to calculation complexity. 
 
4.4 Conclusion 
We have presented a method for decomposing EM by implementing the EM 
decomposition and flux distributions predicted by MEP method, which demonstrations a fast 
and efficient analysis for large-scale metabolic model. The FBA is used to determine many 
possible ranges of metabolic flux distributions that the EM decomposition method requires as 
input data. The MEP is used as an objective function for optimizing the coefficients of 
cEMs/EMs and avoid to the scalar product problem. To demonstrate the feasibility of cEM 
analysis, we predicted the flux distributions of  one synthetic metabolic network, two 
metabolic networks of E. coli and a large-scale metabolic network of head and neck cancer 
cells. The cEM analysis optimized the flux distribution much faster than EM analysis without 
deteriorating the prediction accuracy (Table 4.7). The cEM analysis accurately predicts the 
metabolic flux distributions of metabolic networks of E. coli and it's applicable to 
large/genome–scale metabolic network model. The cEM analysis greatly reduced the 
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computational time and memory cost, enabling analysis of a genome-scale metabolic network. 
It is useful to plan a genetic engineering strategy for large-scale metabolic networks 
producing of useful compounds. 
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Chapter 5 
 
Conclusion, Scope and Future Research Interest 
 
5.1  Conclusion 
 
Metabolism encompasses all life-sustaining biochemical processes and it is playing an 
essential role in various aspects of biology, including the development and progression of 
many serious diseases (Deerardinis and Thompson, 2012). However, metabolism is a highly 
complex of a living cell involves several thousands of small molecules and their conversion, 
a full analysis of such a metabolic network is only feasible using mathematical or 
computational approaches. In addition, metabolism differs significantly from cell to cell and 
over different contexts. Systemic approaches to the study of a biological cell or tissue rely 
increasingly on the use of context-specific metabolic network models. Biological data are 
important in medical area for specified purposes such as patient documentation, disease 
presentation, statistical documentation, etc. The integration of heterogeneous biological data 
and model building have become essential activities in biological research as technological 
advancements continue to empower the measurement of biological data of increasing 
diversity and scale.  
The current central challenge in the development of systems biology is the integration of  
heterogeneous biological data to generate predictive computational models. Modeling and 
simulation of biochemical networks are invaluable tools used by researchers to investigate 
cellular behavior and help in the interpretation of data arising from quantitative experiments. 
Quantitative methods for modeling of biological networks require accurate knowledge of the 
biochemical reactions, their stoichiometric and kinetic parameters, and in the case of 
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metabolic pathway modeling, initial concentrations of metabolites and enzymes (Smallbone  
et al., 2013). In many cases, such experimentally derived parameters are unavailable. 
Therefore, metabolic network analysis becomes a core method for constructing a 
mathematical model that predicts the flux distribution which gives us a good idea of what is 
happening in an organism and how the organisms work under different external environmental 
conditions for large-scale metabolic networks.  
The biochemical reactions which illustrate various portions of the metabolism are 
depicted using a metabolic network. Constraint-based metabolic network analysis has 
focused on two approaches, optimization-based and pathway-based analysis, which are used 
for predicting the steady-state intracellular metabolic fluxes from the metabolic network by  
integrating of the experimental data from genomics, transcriptomics, proteomics, 
metabolomics, and fluxomics, which are determined by high-throughput technologies. The 
FBA, rFBA, MOMA, ROOM, FVA, with some genetically modified algorithms, e.g., 
OptKnock, RobustKnock, OptReg, OptGene, OptGene, OptForce are used to integrate the 
heterogeneous biological data into the metabolic network by the optimization-based analysis 
methods. On the other hand, pathway-based analysis methods, e.g., MFA, EM, Expa, CEF, 
mCEF, ECF, GMF are used to integrate the heterogeneous biological data into metabolic 
network. Integrated biological network analysis is used by IOMA and iMAT to integrate 
quantitative proteomics and metabolomics data, and tissue-specific gene and protein 
expression data with the genome-scale metabolic network. 
However, pathway-based analysis is the most widely used and more advantageous than 
optimization-based analysis, because it generally employs without the specifying the cellular 
objective function. Pathway-based analysis is to offer a great opportunity for studying 
functional and structural properties of metabolic pathways. Pathway-based analysis facilitates 
understanding or designing a complex metabolic system and enables prediction of steady-
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state metabolic flux distributions by EM and Expa analyses. EM analysis is potentially 
effective in integrating  transcriptome or proteome data into metabolic network analyses  and 
minimal set of reactions that can operate in a steady state, while Expa analysis is a subset of 
EM that contains one additional constraint to make all Expas systematically independent. 
EMs/Expas are the building blocks of the metabolic network and it has numerous 
applications in chemical engineering and biochemistry for the study of phenotype of wild 
type and mutant cells under particular conditions.  The EM coefficients (EMCs) indicate the 
quantitative contribution of their associated EMs and can be estimated by maximizing as a 
particular objective function.  
The principal drawback of the ordinary EM/Expa analysis is that the number of EMs/ 
Expas in a metabolic network suffers from a combinatorial explosion. The computational 
time increases exponentially with an increase in network sizes, which demonstrate that the 
computation of the all EMs/Expas expensive and infeasible for large-scale networks. Another 
problem is rising for estimating the EMCs to predict the flux distribution due to no specific 
objective biological functions are available and EMs can be described by different scalar 
products of each EM, but the predicted fluxes must be independent of them. To overcome 
such an existing problem, in this thesis we present a new method to analyze complex 
metabolic networks, cEM analysis. It combines an EM decomposition method, using the 
FBA method, with the MEP to predict the metabolic flux distributions. The predicted flux 
distributions are compared with experimental data and statistically analyzed. 
To demonstrate the feasibility of cEM analysis, we compared it with EM/Expa analysis 
by using an artificial model, two medium-scale metabolic networks of E. coli and a genome-
scale metabolic network of head and neck cancer cells. The cEM analysis greatly reduces the 
number of EM, computational time, memory cost and exposing a new window for a large-
scale metabolic network analysis. The computational timings and accuracy are presented in 
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table 4.7, which clearly show that the cEM method is faster than EM/Expa analyses by CNA 
and emftool. The predicted flux distribution by cEMs analysis is very consistent with that by 
the EM/Expa analyses, whereas they did hardly deteriorated the prediction accuracy. 
Application of cEM analysis to GMF accurately predicts the flux distributions of genetic 
mutants under particular conditions.  
5.2 Scope of the Study 
 
It is very informative and important to analyze the physiological state of microorganisms, 
e.g., cell growth and biosynthesis by metabolic flux distributions, while the flux distribution 
data are not available in human cells, compared with proteome and transcriptome data, due to 
experimental complexity. It is critically important to predict flux distributions from available 
transcriptome and proteome data and to characterize the physiological state of diseased cells. 
This study not only contributes to life science in terms of a complete understanding of 
biological systems, but also gives great influence to advanced biotechnology for analysis of 
genome-scale metabolic networks..  
5.3 Future Research Interest 
 
Considering the previous body of research and undertaken work, future research interest 
may consist of several directions. Some of the major ideas may be outlined as: 
 Human metabolic network analysis by cEM algorithm. 
 Producing of useful compounds from the large-scale metabolic networks by the cEM 
analysis. 
 Predicts metabolic flux distributions of disease- or tissue- specific cells under 
particular conditions. 
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 To develop the disease diagnostic tools from the metabolic network of disease cells 
by the cEM analysis. 
 Establishment of the theoretical validation of cEM analysis. 
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Abbreviations 
ATP   : Adenosine triphosphate  
CEF  : Control effective flux 
cEM  :Complementary elementary mode 
CNA  : CellNetAnalyzer 
COBRA : Constraint-based reconstruction and analysis 
DNA   : Deoxyribonucleic acid  
E. coli  : Escherichia coli 
efmtool : Elementary flux mode tool 
EM  : Elementary mode 
EMC  : Elementary mode coefficient 
ECF  : Enzyme control flux 
EM Decomp : Elementary mode decomposition 
Expa  : Extreme pathway 
ECFLP  : Enzyme control flux linear programing 
FVA  : Flux variability analysis 
FBA  : Flux balance analysis 
GER   : Gene Enzyme Reaction 
GMF  : Genetic modification of flux 
IOMA  : Integrative Omics-Metabolic Analysis 
iMAT  : Integrative Metabolic Analysis Tool  
KEGG  : Kyoto Encyclopedia of Genes and Genomes 
LP  : Linear programming 
mCEF  : Modified control effective flux 
MEP  : Maximum entropy principle 
MILP  : Mixed-integer linear programming 
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MFA  : Metabolic flux analysis 
MM  : Michaelis-Menten  
MOMA : Minimization of metabolic adjustment 
QP  : Quadratic programming 
rFBA   : Regulatory FBA 
ROOM : Regulatory on/off minimization 
SR-FBA  : Steady state Regulatory FBA  
 
Symbols 
S   : Stoichiometric matrix  
v   : Flux vector 
i   : Number of flux 
n   : Total number of flux 
vj   : j-th number of  flux 
l   : Number of metabolites 
m   : Total number of metabolites 
Cl  : Concentration of the l-th metabolite 
ex  : Extracellular metabolite 
R  : Null space matrix 
wt  : Wild-type 
mut  : Mutant-type 
d  : Degrees of freedom 
k   : Number of constraints 
nd   : Number of the measurable /determined fluxes 
Z  : Objective function 
ci   : Weight coefficient for the i-th flux 
lb  : Lower boundaries 
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ub  : Upper boundaries 
KO  : Indices of deleted reactions 
γ  : Specified parameter 
ζ  : Specified parameter 
yi  : Binary variable 
η  : Specified parameter 
ϕ  : Specified parameter 
P   : Elementary mode matrix 
λ   : Elementary mode coefficient 
ei   : ith EM vector 
,i jP   : Normalized element of the i-th reaction in the j-th EM 
γj,SPEOBJ : Ratio of EM output for the specific biological function 
CEFi   : ECF of i-th reaction 
max
SPEOBJP  : Maximum element in the row of biological function 
,SPEOBJ
m
j  : Efficiency of the j-th EM of a genetic mutant for the specific biological 
function 
EAPi   : Relative gene expression for i-th reaction 
i   : Correction factor for i-th reaction 
,gei j   : Gene expression for i-th reaction in the j-th EM 
 mECFi mut  : mECF of the i-th reaction of a mutant type 
 mECFi wt  : mECF of the i-th reaction of a wild type 
 ,i wt mut  : Relative change of a mutant to wild type of mECF 
wt   : EMC of Wild-type 
mut   : EMC of mutant-type 
,i ja   : Relative enzyme activity 
β  : Factor parameter 
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mutv   : Flux distribution of the mutant 
HR    : Highly expressed 
LR    : Lowly expressed  
viirrev  : i-th irreversible flux 
virev  : i-th reversible flux 
p(k)  : Set of cEMs  
K   : The number of cEMs 
λk   : coefficient of k-th cEM  
vd   : Flux vector with d-th determined reactions 
Pd   : Sub-matrix of EM/Expa/cEM matrix 
ρj   : Probability of j-th EM/Expa/cEM 
ne  : Total number of EM/Expa/cEM 
psubstrate uptake,j  : Element of the j-th EM/Expa/cEM 
vsubstrate uptake  : Flux for substrate uptake 
vr   : r-th determined flux 
xr,j   : Converted matrix from EM/Expa/cEM matrix Pd 
jrp ,   : Element of the r-th determined flux and  j-th EM/Expa/cEM 
λi    : Coefficient vector of i-th cEMs/EMs 
ψ   : Nonlinear parameter 
targetv    : Flux distribution of the target model 
target    : EMC of the target model 
numuptake  : Row index that corresponds to the uptake or input flux 
vi,prediction  : Predicted flux for the i-th reaction 
vi,exp   : Experimental data of the i-th reaction 
vg,cEM   : predicted fluxes for the g-th reaction by cEM 
vg, EM/Expa  : Predicted fluxes for the g-th reaction by EM/Expa 
nu   : Number of the unmeasured fluxes. 
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Appendix A.  
Metabolic Network Models 
 
A.1  Escherichia coli (E. coli) 
Table A.1 Metabolic reaction list for E. coli. 
 
 
No 
 
       Gene                                         Reaction
1 Biomass formation 0.14176 Glyc3P + 26.2949 ATP + 0.60097 Ala + 0.10124
Cys + 0.26647Asp + 0.30747 Glu + 0.2048 Phe + 0.67725  
Gly + 0.10473 His + 0.32116 Ile+ 0.37935 Lys + 0.49804 Le
u + 0.16989 Met + 0.26647 Asn + 0.24436 Pro+ 0.29091 Gln
 + 0.32698 Arg + 0.38031 Ser + 0.28044 Thr + 0.46778 Val+
0.062835 Trp + 0.15244 Tyr + 0.1489 rATP + 0.18319rG
TP + 0.11366 rCTP+ 0.12273 rUTP + 
0.023904 dATP + 0.024582 dGTP + 0.024582 dCTP + 
0.023904 dTTP + 0.28352 avg_FS + 0.0069264 
UDPGlc+0.010368 CDPEth+0.010368 OH_myr_ac + 0.0
10368C14_0_FS +0.010368 CMP_KDO + 0.010368 N
DPHep+ 0.0069264 TDPGlcs + 0.1656 UDP_NAG + 
0.01656 UDP_NAM + 0.01656 di_am_pim + 0.0924  
ADPGlc ==> Biomass 
 
2 Nitrogen uptake ==> N
3 CO2 exchange CO2 <==> 
4 Sulfur uptake 4 ATP + 4 NADPH ==> S
5 pts  PEP + GLC ==> G6P + Pyr
6 glk ATP + GLC ==> G6P
7 Succinate exchan   Succ ==> 
8 gps DHAP + NADH <==> Glyc3P
9 Lactate exchange Lac ==>
10 Ethanol exchange Eth ==>
11 Acetate exchange Ac ==>
12 Formate exchange Form ==>
13 pgi G6P <==> F6P
14 fbp F16P ==> F6P
15 fba  F16P <==> DHAP + G3P
16 tpi DHAP <==> G3P
17 gap G3P <==> DPG + NADH
18 pgk DPG <==> 3PG + ATP
19 Gpm 3PG <==> 2PG
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Table A.1  (continued) 
 
20 eno 2PG <==> PEP
21 pyk  PEP ==> Pyr + ATP
22 pps  Pyr + 2 ATP ==> PEP
23 lpd  Pyr ==> AcCoA + NADH + CO2
24 glt  AcCoA + OxA ==> Cit
25 acn Cit <==> ICit
26 icd  ICit <==> alKG + NADPH + CO2
27 sucAB  alKG ==> SuccCoA + NADH + CO2
28 sucCD  SuccCoA <==> Succ + ATP
29 sdh  Succ ==> Fum + QuiH2
30 frd  Fum + QuiH2 ==> Succ
31 Fum  Fum <==> Mal
32 mdh  Mal <==> OxA + NADH
33 aceA  ICit ==> Succ + Glyox
34 aceB  AcCoA + Glyox ==> Mal
35 zwf  G6P <==> PGlac + NADPH
36 adhE  AcCoA + NADH <==> Adh
37 adhE  NADH + Adh <==> Eth
38 pgl  PGlac ==> PGluc
39 gnd  PGluc ==> Rl5P + NADPH + CO2
40 rpe  Rl5P <==> X5P
41 rpi  Rl5P <==> R5P
42 tktAB  R5P + X5P <==> G3P + S7P
43 tal  G3P + S7P <==> F6P + E4P
44 tktAB  E4P + X5P <==> F6P + G3P
45 edd  PGluc ==> KetoPGluc
46 eda  KetoPGluc <==> G3P + Pyr
47 pck  OxA + ATP ==> PEP + CO2
48 ppc  PEP + CO2 ==> OxA
49 pta  AcCoA <==> AcP
50 ack  AcP <==> ATP + Ac
51 pfl  Pyr ==> AcCoA + Form
52 ldh  Pyr + NADH <==> Lac
53 nuo  NADH <==> QuiH2 + 2 H_ex
54 pntA  NADH + H_ex <==> NADPH
55 ATP Synthesis 3 H_ex <==> ATP
56 ATPdrain  ATP ==>
57 aro  2 PEP + E4P + ATP + NADPH ==> Chor
58 prsA  R5P + 2 ATP ==> PRPP
59 met  ATP + NADPH <==> MTHF
60 alaB  Pyr + Glu ==> alKG + Ala
61 avt  2 Pyr + NADPH + Glu ==> alKG + CO2 + Val 
62 ilv 2 Pyr + AcCoA + NADPH + Glu ==> alKG + NADH + 2 C
O2 + Leu 
63 asn 2 ATP + N + Asp ==> Asn
64 asp OxA + Glu ==> alKG + Asp 
65 Lys di_am_pim ==> CO2 + Lys
66 met SuccCoA + ATP + 2 NADPH + MTHF + Cys + 
Asp==> Pyr + Succ + N + Met 
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Table A.1  (continued) 
 
67 thr 2 ATP + 2 NADPH + Asp ==> Thr
68 ilv Pyr + NADPH + Glu + Thr ==> alKG + CO2 + N + Ile 
69 his ATP + PRPP + Gln ==> alKG + 2 NADH + His 
70 gab alKG + NADPH + N ==> Glu
71 gln ATP + N + Glu ==> Gln
72 pro ATP + 2 NADPH + Glu ==> Pro
73 arg AcCoA + 4 ATP + NADPH + CO2 + N + Asp + 2 Glu ==> 
alKG + Fum + Ac + Arg 
74 trp Chor + PRPP + Gln + Ser ==> G3P + Pyr + CO2 + Glu + Trp
75 tyr Chor + Glu ==> alKG + NADH + CO2 + Tyr 
76 phe, tyr Chor + Glu ==> alKG + CO2 + Phe
77 ser 3PG + Glu ==> alKG + NADH + Ser 
78 gly Ser ==> MTHF + Gly
79 cys AcCoA + S + Ser ==> Ac + Cys
80 rATP_Synth 5 ATP + CO2+ PRPP + 2 MTHF + 2 Asp + Gly + 2 Gln ==> 
2 Fum + NADPH + 2 Glu + rATP 
81 rGTP_Synth 6 ATP + CO2 + PRPP + 2 MTHF + 2 Asp + Gly + 3 Gln  
==>2 Fum + NADH + NADPH + 3 Glu + rGTP 
82 rCTP_Synth ATP + Gln + rUTP ==> Glu + rCTP
83 rUTP_Synth 4 ATP + N + PRPP + Asp ==> NADH + rUTP 
84 dATP_Synth NADPH + rATP ==> dATP 
85 dGTP_Synth NADPH + rGTP ==> dGTP
86 dCTP_Synth NADPH + rCTP ==> dCTP
87 dTTP_Synth 2 NADPH + MTHF + rUTP ==> dTTP
88 avg_FS_Synth 8.24 AcCoA + 7.24 ATP + 13.91 NADPH ==> avg_FS 
89 UDPGlc_Synth G6P + ATP ==> UDPGlc
90 CDPEth_Synth 3PG + 3 ATP + NADPH + N ==> NADH + CDPEth 
91 OH_myr_ac_Synth 7 AcCoA + 6 ATP + 11 NADPH ==> OH_myr_ac 
92 C14_0_FS_Synth 7 AcCoA + 6 ATP + 12 NADPH ==> C14_0_FS 
93 CMP_KDO_Synth PEP + R5P + 2 ATP ==> CMP_KDO 
94 NDPHep_Synth 1.5 G6P + ATP ==> 4 NADPH + NDPHep 
95 TDPGlcs_Synth F6P + 2 ATP + N ==> TDPGlcs
96 UDP_NAG_Synth F6P + AcCoA + ATP + Gln ==> Glu + UDP_NAG 
97 UDP_NAM_Synth PEP + NADPH + UDP_NAG ==> UDP_NAM 
98 di_am_pim_Synth Pyr + SuccCoA + ATP + 2 NADPH + Asp + Glu ==> alKG 
+ Succ + di_am_pim 
99 ADPGlc_Synth G6P + ATP ==> ADPGlc
100 Glucose uptake ==> GLC
101 Glycerol exchange Glyc ==>
102 glp Glyc3P ==> ATP + Glyc
103 pfkA F6P + ATP ==> F16P
104 mae Mal ==> Pyr + NADPH + CO2
105 Oxygen uptake ==> O2
106 cyc QuiH2 + 0.5 O2 ==> 2 H_ex 
107 Asnb 2 ATP + Asp + Gln ==> Glu + Asn
108 gltBD alKG + NADPH + Gln ==> 2 Glu
109 Cys S + ASER ==> Ac + Cys
110 ilvB 2 Pyr ==> CO2 + ACLAC
111 ilvC NADPH + ACLAC ==> DHVAL
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112 ilvD DHVAL ==> OIVAL
113 proB ATP + Glu ==> GLUP 
114 proA NADPH + GLUP ==> GLUGSAL
115 aroF PEP + E4P ==> 3DDAH7P
116 aroB 3DDAH7P ==> DQT
117 aroD DQT <==> DHSK
118 aroE NADPH + DHSK <==> SME
119 aroL ATP + SME ==> SME5P
120 aroC PEP + SME5P ==> 3PSME
121 thrA ATP + Asp <==> BASP
122 asd 2 NADPH + BASP <==> HSER
123 metL ATP + HSER ==> PHSER
124 sera 3PG ==> NADH + PHP
125 serC Glu + PHP ==> alKG + 3PSER
126 pheA Chor ==> PHEN
127 pheA2 PHEN ==> CO2 + PHPYR
128 trpDE Chor + Gln ==> Pyr + Glu + AN
129 trpD PRPP + AN ==> NPRAN
130 trpC NPRAN ==> CPAD5P
131 trpC2 CPAD5P ==> CO2 + IGP
132 tyrA PHEN ==> NADH + CO2 + HPHPYR
133 argA AcCoA + Glu ==> NAGLU
134 argB ATP + NAGLU ==> NAGLUYP
135 argC NADPH + NAGLUYP <==> NAGLUSAL 
136 argD Glu + NAGLUSAL <==> alKG + NAARON 
137 argE NAARON ==> Ac + ORN
138 carAB 2 ATP + CO2 + Gln ==> Glu + CAP
139 argFI ORN + CAP <==> CITR
140 argG 2 ATP + Asp + CITR ==> ARGSUCC 
141 ilvA Thr ==> N + OBUT
142 ilvBN Pyr + OBUT ==> CO2 + ABUT
143 ilvC2 NADPH + ABUT ==> DHMVA
144 ilvD2 DHMVA ==> OMVAL
145 hisG ATP + PRPP ==> PRBATP
146 hisI PRBATP ==> PRBAMP
147 hisE PRBAMP ==> PRFP
148 hisA PRFP ==> PRLP
149 hisF Gln + PRLP ==> Glu + DIMGP
150 hisB DIMGP ==> IMACP
151 hisC Glu + IMACP ==> alKG + HISOLP
152 hisB2 HISOLP ==> HISOL
153 metA SuccCoA + HSER ==> OSLHSER
154 metB Cys + OSLHSER ==> Succ + LLCT
155 metC LLCT ==> Pyr + N + HCYS
156 metF NADH + METTHF ==> MTHF
157 leuA AcCoA + OIVAL ==> CBHCAP
158 leuCD CBHCAP <==> IPPMAL
159 leuB IPPMAL ==> NADH + CO2 + OICAP 
 
 
 -131- 
 
Table A.2 Metabolites list for E. coli. 
 
No Abbreviated name Full Name
1 2PG 2-Phosphoglycerate
2 3DDAH7P 3-Deoxy-d-arabino heptulosonate-7-phosphate 
3 3PG 3-Phosphoglycerate
4 3PSER 3-Phosphoserine
5 3PSME 3-Phosphate-shikimate
6 ABUT 2-Aceto-2-hydroxy butyrate
7 Ac Acetate
8 AcCoA Acetyl-CoA
9 ACLAC Acetolactate
10 AcP Acetyl phosphate
11 Adh Acetaldehyde
12 ADPGlc ADPglucose
13 Ala Alanine
14 alKG  alpha-Ketoglutarate
15 AN Antranilate
16 Arg Arginine
17 ARGSUCC L-Arginio succinate
18 ASER O-Acetylserine
19 Asn Asparagine
20 Asp  Aspartate
21 ATP Adenosintriphosphate
22 avg_FS average fatty acid
23 BASP b-Aspartyl phosphate
24 Biomass Biomass
25 C14_0_FS C_14:0_Fatty_acid
26 CAP Carbamoyl phosphate
27 CBHCAP 3-Carboxy-3-hydroxy-isocaproate
28 CDPEth CDP ethanolamine
29 Chor  Chorismate
30 Cit Citrate
31 CITR L-Citrulline
32 CMP_KDO CMP-3-deoxy-D-manno-octulosonate
33 CO2 Carbon dioxide
34 CPAD5P 1-O-Carboxyphenylamino 1-deoxyribulose-5-phosphate
35 Cys Cysteine
36 dATP ATP for DNA synthesis
37 dCTP CTP for DNA synthesis
38 dGTP GTP for DNA synthesis
39 DHAP Dihydroxyacetone phosphate
40 DHMVA 2,3-Dihydroxy-3-methyl-valerate
41 DHSK Dehydroshikimate
42 DHVAL Dihydroxy-isovalerate
43 di_am_pim Diaminopimelate
44 DIMGP D-Erythro imidazoleglycerol-phosphate
45 DPG Diphosphoglycerate
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46 DQT 3-Dehydroquinate
47 dTTP TTP for DNA synthesis
48 E4P D-Erythrose 4-phosphate
49 Eth Ethanol
50 F16P Fructose 1,6-bisphosphate
51 F6P Fructose 6-phosphate
52 Form Formate
53 Fum Fumarate
54 G3P Glyceraldehyde 3-phosphate
55 G6P Glucose 6-phosphate
56 GLC Glucose
57 Gln Glutamine
58 Glu Glutamate
59 GLUGSAL L-Glutamate g-semialdehyde
60 GLUP Glutamyl phosphate
61 Gly Glycine
62 Glyc Glycerol
63 Glyc3P Glycerol 3-phosphate
64 Glyox Glyoxylate
65 H_ex External Hydrogen
66 HCYS Homocysteine
67 His Histidine
68 HISOL Histidinol
69 HISOLP L-Histidinol-phosphate
70 HPHPYR para-Hydroxy phenyl pyruvate
71 HSER Homoserine
72 ICit Isocitrate
73 IGP Indole glycerol phosphate
74 Ile Isoleucine
75 IMACP Imidazole acetyl-phosphate
76 IPPMAL 3-Isopropylmalate
77 KetoPGluc 2-keto-3-deoxy-D-gluconate 6-phosphate
78 Lac Lactate
79 Leu Leucine
80 LLCT L-Cystathionine
81 Lys Lysine
82 Mal Malate
83 Met Methionine
84 METTHF 5,10-Methylene tetrahydrofolate
85 MTHF Methylen-Tetrahydrofolate
86 N Nitrogen(NH4)
87 NAARON N-a-Acetyl ornithine
88 NADH Nicotinamide adenine dinucleotide - reduced 
89 NADPH Nicotinamide adenine dinucleotide phosphate - reduced
90 NAGLU N-Acetyl glutamate
91 NAGLUSAL N-Acetyl glutamate semialdehyde
92 NAGLUYP N-Acetyl glutamyl -phosphate
93 NDPHep NDP Heptose
 
 
 -133- 
 
Table A.2  (continued) 
 
94 NPRAN N-5-phosphoribosyl-antranilate
95 O2 Oxygen
96 OBUT Oxobutyrate or 2-ketobutyrate
97 OH_myr_ac OH myristic Acid
98 OICAP 2-Oxoisocaproate
99 OIVAL Oxoisovalerate
100 OMVAL Oxomethylvalerate
101 ORN Ornithine
102 OSLHSER O-Succinyl-l-homoserine
103 OxA Oxaloacetate
104 PEP Phosphoenolpyruvate
105 PGlac 6-Phospho-Gluconolactone
106 PGluc 6-Phospho-Gluconate
107 Phe Phenylalanine
108 PHEN Prephenate
109 PHP 3-Phosphohydroxypyruvate
110 PHPYR Phenyl pyruvate
111 PHSER O-Phospho-l-homoserine
112 PRBAMP Phosphoribosyl -AMP
113 PRBATP Phosphoribosyl-ATP
114 PRFP Phosphoribosyl-formimino-AICAR-phosphate 
115 PRLP Phosphoribulosyl- formimino-AICAR-phosphate 
116 Pro Proline
117 PRPP 5-Phospho-alpha-D-ribose 1-diphosphate 
118 Pyr Pyruvate
119 QuiH2 Ubichinon_red
120 R5P Ribose 5-phosphate
121 rATP ATP for RNA synthesis
122 rCTP CTP for RNA synthesis
123 rGTP GTP for RNA synthesis
124 Rl5P Ribulose 5-phosphate
125 rUTP UTP for RNA synthesis
126 S Sulfur(SO4)
127 S7P Sedoheptulose 7-phosphate
128 Ser Serine
129 SME Shikimate
130 SME5P Shikimate-5-phosphate
131 Succ Succinate
132 SuccCoA Succinyl-CoA
133 TDPGlcs TDP-glucosamine
134 Thr Threonine
135 Trp Tryptophan
136 Tyr Tyrosine
137 UDP_NAG UDP acetylglucosamine
138 UDP_NAM UDP N-acetylmuramic acid
139 UDPGlc UDP glucose
140 Val Valine
141 X5P Xylolose-5-Phosphate
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Appendix B  
 
 
 
Figure B.1: Metabolic network map for E. coli. Details of the metabolic reactions and metabolites of E. 
coli are shown in Table A.1. 
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Figure B.2: Metabolic pathways for the 4 consistent EMs or cEMs for Model-I. Details of 
the metabolic reactions and metabolites are shown in Table A.1. (Numerical values indicate 
the reaction number, details in Figure B.1). 
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Figure B.3: Metabolic pathways for the 12 consistent EMs or cEMs for Model-II. Details of 
the metabolic reactions and metabolites are shown in Table A.1. 
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Figure B.3 (Continued) 
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Figure B.3 (Continued) 
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Figure B.3 (Continued) 
 
